ICRP 123: positive pion - dawki narządowe i współczynniki jakości
Źródło: ICRP Publication 123, Assessment of Radiation Exposure of Astronauts in Space, supplementary data, Annals of the ICRP 42(4), 2013, strony PDF: arkusz positive pion. Podpis w źródle: Supplementary data workbook P 123 JAICRP 42(4) DB of pion.xls, sheet positive pion
Znormalizowana macierz danych ICRP 123 dla cząstki positive pion: energia, narząd lub wielkość efektywna, płeć fantomu, typ wielkości, jednostka i wartość. Dane obejmują współczynniki konwersji fluencji cząstek na dawkę pochłoniętą oraz średnie współczynniki jakości w geometrii izotropowej.
Źródłowe arkusze miały układ szeroki z wielopoziomowymi nagłówkami; import zapisano w układzie długim, aby można było filtrować po energii, narządzie, płci i typie wielkości.
Kolumny SwTDT/F, DT/F, QICRP60 i QNASA zachowują nazwy źródłowe z arkusza. Jednostka pGy cm2 lub pSv cm2 jest podana w kolumnie jednostka wartości.
Pokazano 7869 z 7869 wierszy.
| Cząstka | Symbol | Z | A | Energia | Jednostka energii | Narząd/tkanka albo wielkość | Płeć/fantom | Wielkość źródłowa | Opis wielkości | Jednostka wartości | Wartość |
|---|---|---|---|---|---|---|---|---|---|---|---|
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 75.5 | ||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 77.4 | ||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 73.7 | ||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.3 | ||
| positive pion | pi+ | 1 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.7 | ||
| positive pion | pi+ | 1 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 170 | ||
| positive pion | pi+ | 1 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 1 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153 | ||
| positive pion | pi+ | 1 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 1 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.8 | ||
| positive pion | pi+ | 1 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.9 | ||
| positive pion | pi+ | 1 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.9 | ||
| positive pion | pi+ | 1 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.7 | ||
| positive pion | pi+ | 1 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.2 | ||
| positive pion | pi+ | 1 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.1 | ||
| positive pion | pi+ | 1 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118 | ||
| positive pion | pi+ | 1 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.1 | ||
| positive pion | pi+ | 1 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.3 | ||
| positive pion | pi+ | 1 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.5 | ||
| positive pion | pi+ | 1 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.8 | ||
| positive pion | pi+ | 1 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.8 | ||
| positive pion | pi+ | 1 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.6 | ||
| positive pion | pi+ | 1 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.6 | ||
| positive pion | pi+ | 1 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.6 | ||
| positive pion | pi+ | 1 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.8 | ||
| positive pion | pi+ | 1 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.2 | ||
| positive pion | pi+ | 1 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.7 | ||
| positive pion | pi+ | 1 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.3 | ||
| positive pion | pi+ | 1 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.9 | ||
| positive pion | pi+ | 1 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104 | ||
| positive pion | pi+ | 1 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.8 | ||
| positive pion | pi+ | 1 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 698 | ||
| positive pion | pi+ | 1 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 773 | ||
| positive pion | pi+ | 1 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52 | ||
| positive pion | pi+ | 1 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.3 | ||
| positive pion | pi+ | 1 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.2 | ||
| positive pion | pi+ | 1 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.6 | ||
| positive pion | pi+ | 1 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97 | ||
| positive pion | pi+ | 1 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.3 | ||
| positive pion | pi+ | 1 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.7 | ||
| positive pion | pi+ | 1 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33.8 | ||
| positive pion | pi+ | 1 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.9 | ||
| positive pion | pi+ | 1 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.5 | ||
| positive pion | pi+ | 1 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.3 | ||
| positive pion | pi+ | 1 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.1 | ||
| positive pion | pi+ | 1 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.4 | ||
| positive pion | pi+ | 1 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.7 | ||
| positive pion | pi+ | 1 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.1 | ||
| positive pion | pi+ | 1 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.2 | ||
| positive pion | pi+ | 1 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74 | ||
| positive pion | pi+ | 1 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.6 | ||
| positive pion | pi+ | 1 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26.9 | ||
| positive pion | pi+ | 1 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.5 | ||
| positive pion | pi+ | 1 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.5 | ||
| positive pion | pi+ | 1 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.2 | ||
| positive pion | pi+ | 1 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.3 | ||
| positive pion | pi+ | 1 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.9 | ||
| positive pion | pi+ | 1 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.4 | ||
| positive pion | pi+ | 1 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.3 | ||
| positive pion | pi+ | 1 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68 | ||
| positive pion | pi+ | 1 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.8 | ||
| positive pion | pi+ | 1 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 197 | ||
| positive pion | pi+ | 1 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 197 | ||
| positive pion | pi+ | 1 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 80 | ||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 82.6 | ||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 77.5 | ||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1.5 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52 | ||
| positive pion | pi+ | 1.5 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.5 | ||
| positive pion | pi+ | 1.5 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198 | ||
| positive pion | pi+ | 1.5 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 1.5 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 167 | ||
| positive pion | pi+ | 1.5 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 1.5 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.8 | ||
| positive pion | pi+ | 1.5 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53 | ||
| positive pion | pi+ | 1.5 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.7 | ||
| positive pion | pi+ | 1.5 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.3 | ||
| positive pion | pi+ | 1.5 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43 | ||
| positive pion | pi+ | 1.5 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.1 | ||
| positive pion | pi+ | 1.5 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118 | ||
| positive pion | pi+ | 1.5 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 1.5 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.1 | ||
| positive pion | pi+ | 1.5 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.6 | ||
| positive pion | pi+ | 1.5 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.6 | ||
| positive pion | pi+ | 1.5 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.4 | ||
| positive pion | pi+ | 1.5 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.7 | ||
| positive pion | pi+ | 1.5 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.9 | ||
| positive pion | pi+ | 1.5 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.9 | ||
| positive pion | pi+ | 1.5 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.7 | ||
| positive pion | pi+ | 1.5 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55 | ||
| positive pion | pi+ | 1.5 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.4 | ||
| positive pion | pi+ | 1.5 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.5 | ||
| positive pion | pi+ | 1.5 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.6 | ||
| positive pion | pi+ | 1.5 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.4 | ||
| positive pion | pi+ | 1.5 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 | ||
| positive pion | pi+ | 1.5 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.8 | ||
| positive pion | pi+ | 1.5 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 751 | ||
| positive pion | pi+ | 1.5 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1.5 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1.5 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 833 | ||
| positive pion | pi+ | 1.5 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1.5 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1.5 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.6 | ||
| positive pion | pi+ | 1.5 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.6 | ||
| positive pion | pi+ | 1.5 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.3 | ||
| positive pion | pi+ | 1.5 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.8 | ||
| positive pion | pi+ | 1.5 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| positive pion | pi+ | 1.5 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1.5 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90 | ||
| positive pion | pi+ | 1.5 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.1 | ||
| positive pion | pi+ | 1.5 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.4 | ||
| positive pion | pi+ | 1.5 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.8 | ||
| positive pion | pi+ | 1.5 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53 | ||
| positive pion | pi+ | 1.5 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.5 | ||
| positive pion | pi+ | 1.5 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.7 | ||
| positive pion | pi+ | 1.5 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.8 | ||
| positive pion | pi+ | 1.5 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.9 | ||
| positive pion | pi+ | 1.5 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.2 | ||
| positive pion | pi+ | 1.5 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.7 | ||
| positive pion | pi+ | 1.5 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75 | ||
| positive pion | pi+ | 1.5 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.8 | ||
| positive pion | pi+ | 1.5 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.2 | ||
| positive pion | pi+ | 1.5 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1.5 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.8 | ||
| positive pion | pi+ | 1.5 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27 | ||
| positive pion | pi+ | 1.5 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.7 | ||
| positive pion | pi+ | 1.5 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.1 | ||
| positive pion | pi+ | 1.5 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.9 | ||
| positive pion | pi+ | 1.5 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.6 | ||
| positive pion | pi+ | 1.5 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.6 | ||
| positive pion | pi+ | 1.5 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.7 | ||
| positive pion | pi+ | 1.5 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.5 | ||
| positive pion | pi+ | 1.5 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 1.5 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 1.5 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 219 | ||
| positive pion | pi+ | 1.5 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1.5 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1.5 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 219 | ||
| positive pion | pi+ | 1.5 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1.5 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 84 | ||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 86.8 | ||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 81.2 | ||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 2 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.5 | ||
| positive pion | pi+ | 2 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 2 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.2 | ||
| positive pion | pi+ | 2 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 2 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 218 | ||
| positive pion | pi+ | 2 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 2 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177 | ||
| positive pion | pi+ | 2 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 2 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.3 | ||
| positive pion | pi+ | 2 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.2 | ||
| positive pion | pi+ | 2 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.1 | ||
| positive pion | pi+ | 2 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.9 | ||
| positive pion | pi+ | 2 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.3 | ||
| positive pion | pi+ | 2 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.6 | ||
| positive pion | pi+ | 2 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117 | ||
| positive pion | pi+ | 2 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 2 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.8 | ||
| positive pion | pi+ | 2 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.4 | ||
| positive pion | pi+ | 2 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56 | ||
| positive pion | pi+ | 2 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.7 | ||
| positive pion | pi+ | 2 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.3 | ||
| positive pion | pi+ | 2 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.4 | ||
| positive pion | pi+ | 2 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 2 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.4 | ||
| positive pion | pi+ | 2 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 2 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.2 | ||
| positive pion | pi+ | 2 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.8 | ||
| positive pion | pi+ | 2 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.6 | ||
| positive pion | pi+ | 2 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.2 | ||
| positive pion | pi+ | 2 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.4 | ||
| positive pion | pi+ | 2 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.9 | ||
| positive pion | pi+ | 2 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116 | ||
| positive pion | pi+ | 2 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.9 | ||
| positive pion | pi+ | 2 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 820 | ||
| positive pion | pi+ | 2 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 2 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 916 | ||
| positive pion | pi+ | 2 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 2 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 | ||
| positive pion | pi+ | 2 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.2 | ||
| positive pion | pi+ | 2 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.2 | ||
| positive pion | pi+ | 2 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.9 | ||
| positive pion | pi+ | 2 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| positive pion | pi+ | 2 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 2 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.7 | ||
| positive pion | pi+ | 2 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.7 | ||
| positive pion | pi+ | 2 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.9 | ||
| positive pion | pi+ | 2 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.7 | ||
| positive pion | pi+ | 2 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.6 | ||
| positive pion | pi+ | 2 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.2 | ||
| positive pion | pi+ | 2 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.1 | ||
| positive pion | pi+ | 2 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.7 | ||
| positive pion | pi+ | 2 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.8 | ||
| positive pion | pi+ | 2 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.9 | ||
| positive pion | pi+ | 2 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78 | ||
| positive pion | pi+ | 2 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77 | ||
| positive pion | pi+ | 2 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.4 | ||
| positive pion | pi+ | 2 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29 | ||
| positive pion | pi+ | 2 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 2 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42 | ||
| positive pion | pi+ | 2 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.9 | ||
| positive pion | pi+ | 2 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33.5 | ||
| positive pion | pi+ | 2 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.9 | ||
| positive pion | pi+ | 2 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46 | ||
| positive pion | pi+ | 2 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.6 | ||
| positive pion | pi+ | 2 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.3 | ||
| positive pion | pi+ | 2 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76 | ||
| positive pion | pi+ | 2 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75 | ||
| positive pion | pi+ | 2 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 2 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 2 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 230 | ||
| positive pion | pi+ | 2 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 2 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 230 | ||
| positive pion | pi+ | 2 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 91.3 | ||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 94.7 | ||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 87.9 | ||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 3 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57 | ||
| positive pion | pi+ | 3 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 3 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.2 | ||
| positive pion | pi+ | 3 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 3 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245 | ||
| positive pion | pi+ | 3 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 3 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 195 | ||
| positive pion | pi+ | 3 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 3 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.5 | ||
| positive pion | pi+ | 3 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.8 | ||
| positive pion | pi+ | 3 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.5 | ||
| positive pion | pi+ | 3 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72 | ||
| positive pion | pi+ | 3 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.2 | ||
| positive pion | pi+ | 3 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.9 | ||
| positive pion | pi+ | 3 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124 | ||
| positive pion | pi+ | 3 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 3 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.6 | ||
| positive pion | pi+ | 3 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48 | ||
| positive pion | pi+ | 3 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59 | ||
| positive pion | pi+ | 3 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.4 | ||
| positive pion | pi+ | 3 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.6 | ||
| positive pion | pi+ | 3 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.1 | ||
| positive pion | pi+ | 3 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.1 | ||
| positive pion | pi+ | 3 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42 | ||
| positive pion | pi+ | 3 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57 | ||
| positive pion | pi+ | 3 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.8 | ||
| positive pion | pi+ | 3 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.2 | ||
| positive pion | pi+ | 3 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.2 | ||
| positive pion | pi+ | 3 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.4 | ||
| positive pion | pi+ | 3 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 3 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127 | ||
| positive pion | pi+ | 3 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 | ||
| positive pion | pi+ | 3 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 954 | ||
| positive pion | pi+ | 3 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 3 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 3 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 3 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.6 | ||
| positive pion | pi+ | 3 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.3 | ||
| positive pion | pi+ | 3 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.6 | ||
| positive pion | pi+ | 3 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.6 | ||
| positive pion | pi+ | 3 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 | ||
| positive pion | pi+ | 3 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 3 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91 | ||
| positive pion | pi+ | 3 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.7 | ||
| positive pion | pi+ | 3 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.4 | ||
| positive pion | pi+ | 3 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47 | ||
| positive pion | pi+ | 3 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.4 | ||
| positive pion | pi+ | 3 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.5 | ||
| positive pion | pi+ | 3 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.5 | ||
| positive pion | pi+ | 3 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.5 | ||
| positive pion | pi+ | 3 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.5 | ||
| positive pion | pi+ | 3 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.1 | ||
| positive pion | pi+ | 3 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.7 | ||
| positive pion | pi+ | 3 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.8 | ||
| positive pion | pi+ | 3 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.5 | ||
| positive pion | pi+ | 3 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.4 | ||
| positive pion | pi+ | 3 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.2 | ||
| positive pion | pi+ | 3 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.6 | ||
| positive pion | pi+ | 3 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.5 | ||
| positive pion | pi+ | 3 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.8 | ||
| positive pion | pi+ | 3 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.5 | ||
| positive pion | pi+ | 3 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.8 | ||
| positive pion | pi+ | 3 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64 | ||
| positive pion | pi+ | 3 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.6 | ||
| positive pion | pi+ | 3 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 3 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.1 | ||
| positive pion | pi+ | 3 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 3 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 3 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 249 | ||
| positive pion | pi+ | 3 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 3 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 249 | ||
| positive pion | pi+ | 3 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 99 | ||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 103 | ||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 95.1 | ||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 4 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.1 | ||
| positive pion | pi+ | 4 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 4 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 | ||
| positive pion | pi+ | 4 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 4 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 269 | ||
| positive pion | pi+ | 4 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 4 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 215 | ||
| positive pion | pi+ | 4 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 4 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.9 | ||
| positive pion | pi+ | 4 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.5 | ||
| positive pion | pi+ | 4 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.8 | ||
| positive pion | pi+ | 4 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.7 | ||
| positive pion | pi+ | 4 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.6 | ||
| positive pion | pi+ | 4 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.5 | ||
| positive pion | pi+ | 4 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 | ||
| positive pion | pi+ | 4 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 4 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.5 | ||
| positive pion | pi+ | 4 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.8 | ||
| positive pion | pi+ | 4 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.8 | ||
| positive pion | pi+ | 4 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48.5 | ||
| positive pion | pi+ | 4 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.7 | ||
| positive pion | pi+ | 4 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.6 | ||
| positive pion | pi+ | 4 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.6 | ||
| positive pion | pi+ | 4 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45 | ||
| positive pion | pi+ | 4 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.4 | ||
| positive pion | pi+ | 4 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.1 | ||
| positive pion | pi+ | 4 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89 | ||
| positive pion | pi+ | 4 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.5 | ||
| positive pion | pi+ | 4 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.9 | ||
| positive pion | pi+ | 4 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140 | ||
| positive pion | pi+ | 4 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116 | ||
| positive pion | pi+ | 4 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| positive pion | pi+ | 4 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 4 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.8 | ||
| positive pion | pi+ | 4 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.5 | ||
| positive pion | pi+ | 4 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.4 | ||
| positive pion | pi+ | 4 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 4 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.4 | ||
| positive pion | pi+ | 4 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 4 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133 | ||
| positive pion | pi+ | 4 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 4 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.3 | ||
| positive pion | pi+ | 4 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.2 | ||
| positive pion | pi+ | 4 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.5 | ||
| positive pion | pi+ | 4 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.8 | ||
| positive pion | pi+ | 4 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.5 | ||
| positive pion | pi+ | 4 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46.9 | ||
| positive pion | pi+ | 4 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.3 | ||
| positive pion | pi+ | 4 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.3 | ||
| positive pion | pi+ | 4 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.9 | ||
| positive pion | pi+ | 4 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.7 | ||
| positive pion | pi+ | 4 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.5 | ||
| positive pion | pi+ | 4 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.5 | ||
| positive pion | pi+ | 4 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104 | ||
| positive pion | pi+ | 4 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.5 | ||
| positive pion | pi+ | 4 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.3 | ||
| positive pion | pi+ | 4 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35 | ||
| positive pion | pi+ | 4 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.4 | ||
| positive pion | pi+ | 4 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.8 | ||
| positive pion | pi+ | 4 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.9 | ||
| positive pion | pi+ | 4 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.5 | ||
| positive pion | pi+ | 4 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.9 | ||
| positive pion | pi+ | 4 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.6 | ||
| positive pion | pi+ | 4 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.8 | ||
| positive pion | pi+ | 4 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 4 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 4 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 280 | ||
| positive pion | pi+ | 4 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 280 | ||
| positive pion | pi+ | 4 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 108 | ||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 112 | ||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 103 | ||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 5 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.4 | ||
| positive pion | pi+ | 5 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 5 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.5 | ||
| positive pion | pi+ | 5 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 5 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 302 | ||
| positive pion | pi+ | 5 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 5 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 5 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 246 | ||
| positive pion | pi+ | 5 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 5 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.5 | ||
| positive pion | pi+ | 5 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.2 | ||
| positive pion | pi+ | 5 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.7 | ||
| positive pion | pi+ | 5 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.8 | ||
| positive pion | pi+ | 5 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.5 | ||
| positive pion | pi+ | 5 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.8 | ||
| positive pion | pi+ | 5 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 157 | ||
| positive pion | pi+ | 5 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 5 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.1 | ||
| positive pion | pi+ | 5 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.8 | ||
| positive pion | pi+ | 5 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.7 | ||
| positive pion | pi+ | 5 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.7 | ||
| positive pion | pi+ | 5 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.5 | ||
| positive pion | pi+ | 5 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 | ||
| positive pion | pi+ | 5 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 | ||
| positive pion | pi+ | 5 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.9 | ||
| positive pion | pi+ | 5 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70 | ||
| positive pion | pi+ | 5 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.5 | ||
| positive pion | pi+ | 5 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95.3 | ||
| positive pion | pi+ | 5 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.8 | ||
| positive pion | pi+ | 5 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93.9 | ||
| positive pion | pi+ | 5 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 5 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151 | ||
| positive pion | pi+ | 5 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127 | ||
| positive pion | pi+ | 5 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 5 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 5 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| positive pion | pi+ | 5 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 5 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68 | ||
| positive pion | pi+ | 5 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.5 | ||
| positive pion | pi+ | 5 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.8 | ||
| positive pion | pi+ | 5 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.5 | ||
| positive pion | pi+ | 5 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143 | ||
| positive pion | pi+ | 5 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 5 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107 | ||
| positive pion | pi+ | 5 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47 | ||
| positive pion | pi+ | 5 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.1 | ||
| positive pion | pi+ | 5 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.8 | ||
| positive pion | pi+ | 5 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.6 | ||
| positive pion | pi+ | 5 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.9 | ||
| positive pion | pi+ | 5 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 | ||
| positive pion | pi+ | 5 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.7 | ||
| positive pion | pi+ | 5 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77.8 | ||
| positive pion | pi+ | 5 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 | ||
| positive pion | pi+ | 5 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94.5 | ||
| positive pion | pi+ | 5 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93.9 | ||
| positive pion | pi+ | 5 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 | ||
| positive pion | pi+ | 5 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.7 | ||
| positive pion | pi+ | 5 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.3 | ||
| positive pion | pi+ | 5 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37.4 | ||
| positive pion | pi+ | 5 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.8 | ||
| positive pion | pi+ | 5 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51 | ||
| positive pion | pi+ | 5 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.7 | ||
| positive pion | pi+ | 5 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.8 | ||
| positive pion | pi+ | 5 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.7 | ||
| positive pion | pi+ | 5 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.4 | ||
| positive pion | pi+ | 5 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.5 | ||
| positive pion | pi+ | 5 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 5 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 5 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 321 | ||
| positive pion | pi+ | 5 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 5 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 321 | ||
| positive pion | pi+ | 5 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 116 | ||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 122 | ||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 110 | ||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.1 | ||
| positive pion | pi+ | 6 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 6 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.6 | ||
| positive pion | pi+ | 6 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 6 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 347 | ||
| positive pion | pi+ | 6 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 6 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 6 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 283 | ||
| positive pion | pi+ | 6 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 6 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 6 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.7 | ||
| positive pion | pi+ | 6 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.2 | ||
| positive pion | pi+ | 6 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.1 | ||
| positive pion | pi+ | 6 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.5 | ||
| positive pion | pi+ | 6 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.1 | ||
| positive pion | pi+ | 6 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72 | ||
| positive pion | pi+ | 6 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172 | ||
| positive pion | pi+ | 6 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.6 | ||
| positive pion | pi+ | 6 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.1 | ||
| positive pion | pi+ | 6 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.7 | ||
| positive pion | pi+ | 6 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.7 | ||
| positive pion | pi+ | 6 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.8 | ||
| positive pion | pi+ | 6 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| positive pion | pi+ | 6 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| positive pion | pi+ | 6 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50 | ||
| positive pion | pi+ | 6 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 6 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.5 | ||
| positive pion | pi+ | 6 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103 | ||
| positive pion | pi+ | 6 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101 | ||
| positive pion | pi+ | 6 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92 | ||
| positive pion | pi+ | 6 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.5 | ||
| positive pion | pi+ | 6 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 162 | ||
| positive pion | pi+ | 6 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136 | ||
| positive pion | pi+ | 6 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| positive pion | pi+ | 6 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| positive pion | pi+ | 6 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.9 | ||
| positive pion | pi+ | 6 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.7 | ||
| positive pion | pi+ | 6 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47 | ||
| positive pion | pi+ | 6 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54 | ||
| positive pion | pi+ | 6 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154 | ||
| positive pion | pi+ | 6 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 6 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116 | ||
| positive pion | pi+ | 6 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.2 | ||
| positive pion | pi+ | 6 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54 | ||
| positive pion | pi+ | 6 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.4 | ||
| positive pion | pi+ | 6 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.3 | ||
| positive pion | pi+ | 6 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.5 | ||
| positive pion | pi+ | 6 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.8 | ||
| positive pion | pi+ | 6 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.9 | ||
| positive pion | pi+ | 6 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82.4 | ||
| positive pion | pi+ | 6 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 | ||
| positive pion | pi+ | 6 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.9 | ||
| positive pion | pi+ | 6 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.1 | ||
| positive pion | pi+ | 6 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 | ||
| positive pion | pi+ | 6 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33.6 | ||
| positive pion | pi+ | 6 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.2 | ||
| positive pion | pi+ | 6 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.8 | ||
| positive pion | pi+ | 6 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.6 | ||
| positive pion | pi+ | 6 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53.4 | ||
| positive pion | pi+ | 6 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.9 | ||
| positive pion | pi+ | 6 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61 | ||
| positive pion | pi+ | 6 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.1 | ||
| positive pion | pi+ | 6 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.8 | ||
| positive pion | pi+ | 6 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.9 | ||
| positive pion | pi+ | 6 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 6 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 6 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 | ||
| positive pion | pi+ | 6 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 | ||
| positive pion | pi+ | 6 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 132 | ||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 141 | ||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 123 | ||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 8 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.2 | ||
| positive pion | pi+ | 8 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 8 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.7 | ||
| positive pion | pi+ | 8 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 8 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 8 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 369 | ||
| positive pion | pi+ | 8 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 8 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.9 | ||
| positive pion | pi+ | 8 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.1 | ||
| positive pion | pi+ | 8 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.3 | ||
| positive pion | pi+ | 8 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.9 | ||
| positive pion | pi+ | 8 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.4 | ||
| positive pion | pi+ | 8 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74.9 | ||
| positive pion | pi+ | 8 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 196 | ||
| positive pion | pi+ | 8 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 8 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.7 | ||
| positive pion | pi+ | 8 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.5 | ||
| positive pion | pi+ | 8 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.4 | ||
| positive pion | pi+ | 8 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.5 | ||
| positive pion | pi+ | 8 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.7 | ||
| positive pion | pi+ | 8 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 | ||
| positive pion | pi+ | 8 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 | ||
| positive pion | pi+ | 8 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.7 | ||
| positive pion | pi+ | 8 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.2 | ||
| positive pion | pi+ | 8 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 | ||
| positive pion | pi+ | 8 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111 | ||
| positive pion | pi+ | 8 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.6 | ||
| positive pion | pi+ | 8 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| positive pion | pi+ | 8 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 192 | ||
| positive pion | pi+ | 8 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149 | ||
| positive pion | pi+ | 8 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 8 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 8 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 8 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 8 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79 | ||
| positive pion | pi+ | 8 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.8 | ||
| positive pion | pi+ | 8 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.6 | ||
| positive pion | pi+ | 8 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57 | ||
| positive pion | pi+ | 8 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 183 | ||
| positive pion | pi+ | 8 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 8 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134 | ||
| positive pion | pi+ | 8 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.9 | ||
| positive pion | pi+ | 8 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.3 | ||
| positive pion | pi+ | 8 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.5 | ||
| positive pion | pi+ | 8 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.8 | ||
| positive pion | pi+ | 8 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.8 | ||
| positive pion | pi+ | 8 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.1 | ||
| positive pion | pi+ | 8 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| positive pion | pi+ | 8 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.1 | ||
| positive pion | pi+ | 8 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126 | ||
| positive pion | pi+ | 8 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109 | ||
| positive pion | pi+ | 8 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103 | ||
| positive pion | pi+ | 8 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130 | ||
| positive pion | pi+ | 8 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35 | ||
| positive pion | pi+ | 8 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.8 | ||
| positive pion | pi+ | 8 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.8 | ||
| positive pion | pi+ | 8 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.7 | ||
| positive pion | pi+ | 8 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 55.8 | ||
| positive pion | pi+ | 8 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.4 | ||
| positive pion | pi+ | 8 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65 | ||
| positive pion | pi+ | 8 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.9 | ||
| positive pion | pi+ | 8 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.2 | ||
| positive pion | pi+ | 8 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97.1 | ||
| positive pion | pi+ | 8 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 8 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 8 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 8 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 8 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 8 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 8 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 148 | ||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 160 | ||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 135 | ||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 10 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.3 | ||
| positive pion | pi+ | 10 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 10 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.2 | ||
| positive pion | pi+ | 10 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |||
| positive pion | pi+ | 10 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 10 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 447 | ||
| positive pion | pi+ | 10 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 10 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74 | ||
| positive pion | pi+ | 10 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.2 | ||
| positive pion | pi+ | 10 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.5 | ||
| positive pion | pi+ | 10 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.7 | ||
| positive pion | pi+ | 10 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.4 | ||
| positive pion | pi+ | 10 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.3 | ||
| positive pion | pi+ | 10 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 223 | ||
| positive pion | pi+ | 10 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 10 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44 | ||
| positive pion | pi+ | 10 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.3 | ||
| positive pion | pi+ | 10 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76.9 | ||
| positive pion | pi+ | 10 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.6 | ||
| positive pion | pi+ | 10 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.2 | ||
| positive pion | pi+ | 10 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128 | ||
| positive pion | pi+ | 10 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128 | ||
| positive pion | pi+ | 10 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.2 | ||
| positive pion | pi+ | 10 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.1 | ||
| positive pion | pi+ | 10 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124 | ||
| positive pion | pi+ | 10 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 | ||
| positive pion | pi+ | 10 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103 | ||
| positive pion | pi+ | 10 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110 | ||
| positive pion | pi+ | 10 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 235 | ||
| positive pion | pi+ | 10 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 10 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 170 | ||
| positive pion | pi+ | 10 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 10 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 930 | ||
| positive pion | pi+ | 10 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 10 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 925 | ||
| positive pion | pi+ | 10 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 10 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.2 | ||
| positive pion | pi+ | 10 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.1 | ||
| positive pion | pi+ | 10 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54.3 | ||
| positive pion | pi+ | 10 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.2 | ||
| positive pion | pi+ | 10 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 218 | ||
| positive pion | pi+ | 10 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 10 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151 | ||
| positive pion | pi+ | 10 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.1 | ||
| positive pion | pi+ | 10 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.6 | ||
| positive pion | pi+ | 10 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.6 | ||
| positive pion | pi+ | 10 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75.7 | ||
| positive pion | pi+ | 10 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.4 | ||
| positive pion | pi+ | 10 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.7 | ||
| positive pion | pi+ | 10 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123 | ||
| positive pion | pi+ | 10 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.5 | ||
| positive pion | pi+ | 10 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143 | ||
| positive pion | pi+ | 10 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 | ||
| positive pion | pi+ | 10 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 | ||
| positive pion | pi+ | 10 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 | ||
| positive pion | pi+ | 10 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35.6 | ||
| positive pion | pi+ | 10 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57.9 | ||
| positive pion | pi+ | 10 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.3 | ||
| positive pion | pi+ | 10 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.6 | ||
| positive pion | pi+ | 10 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.2 | ||
| positive pion | pi+ | 10 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.7 | ||
| positive pion | pi+ | 10 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.9 | ||
| positive pion | pi+ | 10 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.9 | ||
| positive pion | pi+ | 10 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 | ||
| positive pion | pi+ | 10 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104 | ||
| positive pion | pi+ | 10 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 10 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 10 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 656 | ||
| positive pion | pi+ | 10 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 10 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 656 | ||
| positive pion | pi+ | 10 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 10 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 184 | ||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 200 | ||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 167 | ||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 | ||
| positive pion | pi+ | 15 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114 | ||
| positive pion | pi+ | 15 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 772 | ||
| positive pion | pi+ | 15 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 15 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 15 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 15 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.9 | ||
| positive pion | pi+ | 15 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.3 | ||
| positive pion | pi+ | 15 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91 | ||
| positive pion | pi+ | 15 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| positive pion | pi+ | 15 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.1 | ||
| positive pion | pi+ | 15 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93.7 | ||
| positive pion | pi+ | 15 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 297 | ||
| positive pion | pi+ | 15 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 15 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.2 | ||
| positive pion | pi+ | 15 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71.5 | ||
| positive pion | pi+ | 15 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.6 | ||
| positive pion | pi+ | 15 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.5 | ||
| positive pion | pi+ | 15 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.1 | ||
| positive pion | pi+ | 15 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147 | ||
| positive pion | pi+ | 15 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161 | ||
| positive pion | pi+ | 15 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61 | ||
| positive pion | pi+ | 15 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132 | ||
| positive pion | pi+ | 15 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 179 | ||
| positive pion | pi+ | 15 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177 | ||
| positive pion | pi+ | 15 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122 | ||
| positive pion | pi+ | 15 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 138 | ||
| positive pion | pi+ | 15 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| positive pion | pi+ | 15 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 276 | ||
| positive pion | pi+ | 15 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 726 | ||
| positive pion | pi+ | 15 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 723 | ||
| positive pion | pi+ | 15 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114 | ||
| positive pion | pi+ | 15 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 | ||
| positive pion | pi+ | 15 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.4 | ||
| positive pion | pi+ | 15 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.9 | ||
| positive pion | pi+ | 15 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 324 | ||
| positive pion | pi+ | 15 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 15 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 207 | ||
| positive pion | pi+ | 15 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.2 | ||
| positive pion | pi+ | 15 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63.9 | ||
| positive pion | pi+ | 15 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.3 | ||
| positive pion | pi+ | 15 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.2 | ||
| positive pion | pi+ | 15 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.8 | ||
| positive pion | pi+ | 15 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.8 | ||
| positive pion | pi+ | 15 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173 | ||
| positive pion | pi+ | 15 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 | ||
| positive pion | pi+ | 15 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 212 | ||
| positive pion | pi+ | 15 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 15 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161 | ||
| positive pion | pi+ | 15 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148 | ||
| positive pion | pi+ | 15 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181 | ||
| positive pion | pi+ | 15 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.3 | ||
| positive pion | pi+ | 15 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.9 | ||
| positive pion | pi+ | 15 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.9 | ||
| positive pion | pi+ | 15 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 50.1 | ||
| positive pion | pi+ | 15 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.5 | ||
| positive pion | pi+ | 15 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.5 | ||
| positive pion | pi+ | 15 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.4 | ||
| positive pion | pi+ | 15 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.6 | ||
| positive pion | pi+ | 15 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137 | ||
| positive pion | pi+ | 15 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134 | ||
| positive pion | pi+ | 15 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 15 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 732 | ||
| positive pion | pi+ | 15 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 732 | ||
| positive pion | pi+ | 15 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 15 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 220 | ||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 234 | ||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 205 | ||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148 | ||
| positive pion | pi+ | 20 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 155 | ||
| positive pion | pi+ | 20 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| positive pion | pi+ | 20 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 20 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 645 | ||
| positive pion | pi+ | 20 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 20 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 | ||
| positive pion | pi+ | 20 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109 | ||
| positive pion | pi+ | 20 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 | ||
| positive pion | pi+ | 20 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132 | ||
| positive pion | pi+ | 20 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86.3 | ||
| positive pion | pi+ | 20 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124 | ||
| positive pion | pi+ | 20 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 365 | ||
| positive pion | pi+ | 20 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 20 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62.5 | ||
| positive pion | pi+ | 20 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.8 | ||
| positive pion | pi+ | 20 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117 | ||
| positive pion | pi+ | 20 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.5 | ||
| positive pion | pi+ | 20 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104 | ||
| positive pion | pi+ | 20 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 279 | ||
| positive pion | pi+ | 20 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 310 | ||
| positive pion | pi+ | 20 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.9 | ||
| positive pion | pi+ | 20 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 193 | ||
| positive pion | pi+ | 20 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 266 | ||
| positive pion | pi+ | 20 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 257 | ||
| positive pion | pi+ | 20 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172 | ||
| positive pion | pi+ | 20 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 201 | ||
| positive pion | pi+ | 20 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 20 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 20 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 390 | ||
| positive pion | pi+ | 20 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 20 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 | ||
| positive pion | pi+ | 20 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 | ||
| positive pion | pi+ | 20 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 143 | ||
| positive pion | pi+ | 20 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139 | ||
| positive pion | pi+ | 20 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78.1 | ||
| positive pion | pi+ | 20 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.3 | ||
| positive pion | pi+ | 20 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 393 | ||
| positive pion | pi+ | 20 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 20 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 289 | ||
| positive pion | pi+ | 20 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.9 | ||
| positive pion | pi+ | 20 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.9 | ||
| positive pion | pi+ | 20 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.9 | ||
| positive pion | pi+ | 20 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| positive pion | pi+ | 20 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72.9 | ||
| positive pion | pi+ | 20 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.2 | ||
| positive pion | pi+ | 20 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 207 | ||
| positive pion | pi+ | 20 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 192 | ||
| positive pion | pi+ | 20 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 301 | ||
| positive pion | pi+ | 20 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 234 | ||
| positive pion | pi+ | 20 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194 | ||
| positive pion | pi+ | 20 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 238 | ||
| positive pion | pi+ | 20 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.9 | ||
| positive pion | pi+ | 20 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70.7 | ||
| positive pion | pi+ | 20 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51.6 | ||
| positive pion | pi+ | 20 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.7 | ||
| positive pion | pi+ | 20 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.9 | ||
| positive pion | pi+ | 20 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90.5 | ||
| positive pion | pi+ | 20 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92.9 | ||
| positive pion | pi+ | 20 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120 | ||
| positive pion | pi+ | 20 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 20 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 194 | ||
| positive pion | pi+ | 20 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 20 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198 | ||
| positive pion | pi+ | 20 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 663 | ||
| positive pion | pi+ | 20 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 20 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 663 | ||
| positive pion | pi+ | 20 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 20 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 301 | ||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 304 | ||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 298 | ||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 239 | ||
| positive pion | pi+ | 30 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 254 | ||
| positive pion | pi+ | 30 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 672 | ||
| positive pion | pi+ | 30 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 30 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 232 | ||
| positive pion | pi+ | 30 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 250 | ||
| positive pion | pi+ | 30 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 204 | ||
| positive pion | pi+ | 30 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 251 | ||
| positive pion | pi+ | 30 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177 | ||
| positive pion | pi+ | 30 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 255 | ||
| positive pion | pi+ | 30 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 467 | ||
| positive pion | pi+ | 30 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 30 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.8 | ||
| positive pion | pi+ | 30 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 172 | ||
| positive pion | pi+ | 30 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 236 | ||
| positive pion | pi+ | 30 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154 | ||
| positive pion | pi+ | 30 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 202 | ||
| positive pion | pi+ | 30 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 | ||
| positive pion | pi+ | 30 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| positive pion | pi+ | 30 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134 | ||
| positive pion | pi+ | 30 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 279 | ||
| positive pion | pi+ | 30 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| positive pion | pi+ | 30 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 424 | ||
| positive pion | pi+ | 30 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 384 | ||
| positive pion | pi+ | 30 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| positive pion | pi+ | 30 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 30 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 30 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 30 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 30 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 30 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 30 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 221 | ||
| positive pion | pi+ | 30 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 235 | ||
| positive pion | pi+ | 30 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102 | ||
| positive pion | pi+ | 30 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 | ||
| positive pion | pi+ | 30 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 30 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 30 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 362 | ||
| positive pion | pi+ | 30 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 | ||
| positive pion | pi+ | 30 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114 | ||
| positive pion | pi+ | 30 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 159 | ||
| positive pion | pi+ | 30 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 208 | ||
| positive pion | pi+ | 30 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107 | ||
| positive pion | pi+ | 30 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132 | ||
| positive pion | pi+ | 30 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 265 | ||
| positive pion | pi+ | 30 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 278 | ||
| positive pion | pi+ | 30 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 448 | ||
| positive pion | pi+ | 30 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| positive pion | pi+ | 30 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 309 | ||
| positive pion | pi+ | 30 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 | ||
| positive pion | pi+ | 30 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.9 | ||
| positive pion | pi+ | 30 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108 | ||
| positive pion | pi+ | 30 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.7 | ||
| positive pion | pi+ | 30 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90 | ||
| positive pion | pi+ | 30 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 30 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 158 | ||
| positive pion | pi+ | 30 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 173 | ||
| positive pion | pi+ | 30 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 157 | ||
| positive pion | pi+ | 30 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 243 | ||
| positive pion | pi+ | 30 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| positive pion | pi+ | 30 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| positive pion | pi+ | 30 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| positive pion | pi+ | 30 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 30 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| positive pion | pi+ | 30 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 30 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 393 | ||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 384 | ||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 403 | ||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 343 | ||
| positive pion | pi+ | 40 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 373 | ||
| positive pion | pi+ | 40 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 40 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 40 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 364 | ||
| positive pion | pi+ | 40 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 400 | ||
| positive pion | pi+ | 40 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| positive pion | pi+ | 40 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 40 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 304 | ||
| positive pion | pi+ | 40 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| positive pion | pi+ | 40 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 446 | ||
| positive pion | pi+ | 40 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130 | ||
| positive pion | pi+ | 40 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 40 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 293 | ||
| positive pion | pi+ | 40 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 | ||
| positive pion | pi+ | 40 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 259 | ||
| positive pion | pi+ | 40 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 282 | ||
| positive pion | pi+ | 40 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 457 | ||
| positive pion | pi+ | 40 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| positive pion | pi+ | 40 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 238 | ||
| positive pion | pi+ | 40 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 342 | ||
| positive pion | pi+ | 40 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| positive pion | pi+ | 40 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 40 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 40 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| positive pion | pi+ | 40 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| positive pion | pi+ | 40 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 40 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 40 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 40 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 40 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 40 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 333 | ||
| positive pion | pi+ | 40 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 361 | ||
| positive pion | pi+ | 40 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 259 | ||
| positive pion | pi+ | 40 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 209 | ||
| positive pion | pi+ | 40 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 40 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 40 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 219 | ||
| positive pion | pi+ | 40 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 221 | ||
| positive pion | pi+ | 40 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 283 | ||
| positive pion | pi+ | 40 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 368 | ||
| positive pion | pi+ | 40 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 265 | ||
| positive pion | pi+ | 40 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 283 | ||
| positive pion | pi+ | 40 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 345 | ||
| positive pion | pi+ | 40 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 381 | ||
| positive pion | pi+ | 40 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 40 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 40 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| positive pion | pi+ | 40 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| positive pion | pi+ | 40 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 | ||
| positive pion | pi+ | 40 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 234 | ||
| positive pion | pi+ | 40 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129 | ||
| positive pion | pi+ | 40 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |||
| positive pion | pi+ | 40 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 177 | ||
| positive pion | pi+ | 40 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 275 | ||
| positive pion | pi+ | 40 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 301 | ||
| positive pion | pi+ | 40 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 349 | ||
| positive pion | pi+ | 40 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| positive pion | pi+ | 40 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 | ||
| positive pion | pi+ | 40 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 394 | ||
| positive pion | pi+ | 40 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 40 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 40 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 40 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 40 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 40 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 476 | ||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 459 | ||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 445 | ||
| positive pion | pi+ | 50 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 50 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| positive pion | pi+ | 50 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 50 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 454 | ||
| positive pion | pi+ | 50 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 50 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| positive pion | pi+ | 50 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 636 | ||
| positive pion | pi+ | 50 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 421 | ||
| positive pion | pi+ | 50 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 50 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 376 | ||
| positive pion | pi+ | 50 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 335 | ||
| positive pion | pi+ | 50 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| positive pion | pi+ | 50 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 50 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 402 | ||
| positive pion | pi+ | 50 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 50 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 50 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| positive pion | pi+ | 50 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 359 | ||
| positive pion | pi+ | 50 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 399 | ||
| positive pion | pi+ | 50 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 50 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| positive pion | pi+ | 50 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 730 | ||
| positive pion | pi+ | 50 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 749 | ||
| positive pion | pi+ | 50 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| positive pion | pi+ | 50 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 596 | ||
| positive pion | pi+ | 50 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| positive pion | pi+ | 50 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 50 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| positive pion | pi+ | 50 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| positive pion | pi+ | 50 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 416 | ||
| positive pion | pi+ | 50 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 374 | ||
| positive pion | pi+ | 50 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| positive pion | pi+ | 50 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| positive pion | pi+ | 50 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 350 | ||
| positive pion | pi+ | 50 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 375 | ||
| positive pion | pi+ | 50 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 422 | ||
| positive pion | pi+ | 50 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 50 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 430 | ||
| positive pion | pi+ | 50 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| positive pion | pi+ | 50 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| positive pion | pi+ | 50 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 50 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| positive pion | pi+ | 50 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 50 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 720 | ||
| positive pion | pi+ | 50 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| positive pion | pi+ | 50 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 223 | ||
| positive pion | pi+ | 50 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 50 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 321 | ||
| positive pion | pi+ | 50 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 328 | ||
| positive pion | pi+ | 50 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 397 | ||
| positive pion | pi+ | 50 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 429 | ||
| positive pion | pi+ | 50 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 50 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 50 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 441 | ||
| positive pion | pi+ | 50 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| positive pion | pi+ | 50 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 50 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| positive pion | pi+ | 50 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 50 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| positive pion | pi+ | 50 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 570 | ||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 60 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| positive pion | pi+ | 60 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| positive pion | pi+ | 60 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| positive pion | pi+ | 60 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 60 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 509 | ||
| positive pion | pi+ | 60 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| positive pion | pi+ | 60 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 659 | ||
| positive pion | pi+ | 60 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| positive pion | pi+ | 60 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 60 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| positive pion | pi+ | 60 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 60 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 | ||
| positive pion | pi+ | 60 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| positive pion | pi+ | 60 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 650 | ||
| positive pion | pi+ | 60 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 690 | ||
| positive pion | pi+ | 60 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 591 | ||
| positive pion | pi+ | 60 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| positive pion | pi+ | 60 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 465 | ||
| positive pion | pi+ | 60 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| positive pion | pi+ | 60 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 595 | ||
| positive pion | pi+ | 60 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| positive pion | pi+ | 60 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 741 | ||
| positive pion | pi+ | 60 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 734 | ||
| positive pion | pi+ | 60 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| positive pion | pi+ | 60 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 615 | ||
| positive pion | pi+ | 60 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| positive pion | pi+ | 60 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 60 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 537 | ||
| positive pion | pi+ | 60 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 60 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 419 | ||
| positive pion | pi+ | 60 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| positive pion | pi+ | 60 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 679 | ||
| positive pion | pi+ | 60 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 663 | ||
| positive pion | pi+ | 60 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 60 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| positive pion | pi+ | 60 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 60 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| positive pion | pi+ | 60 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 60 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 60 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 60 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 60 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 60 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 60 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 691 | ||
| positive pion | pi+ | 60 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 658 | ||
| positive pion | pi+ | 60 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 60 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 60 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 60 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 502 | ||
| positive pion | pi+ | 60 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.3 | |||
| positive pion | pi+ | 60 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 60 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 60 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 60 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| positive pion | pi+ | 60 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 60 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 60 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| positive pion | pi+ | 60 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| positive pion | pi+ | 60 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| positive pion | pi+ | 60 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 60 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 591 | ||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 80 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 80 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 591 | ||
| positive pion | pi+ | 80 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 80 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 80 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 80 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 80 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 573 | ||
| positive pion | pi+ | 80 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| positive pion | pi+ | 80 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 80 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| positive pion | pi+ | 80 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| positive pion | pi+ | 80 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 80 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 635 | ||
| positive pion | pi+ | 80 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 80 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| positive pion | pi+ | 80 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 583 | ||
| positive pion | pi+ | 80 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| positive pion | pi+ | 80 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 661 | ||
| positive pion | pi+ | 80 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 551 | ||
| positive pion | pi+ | 80 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 80 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 80 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 603 | ||
| positive pion | pi+ | 80 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| positive pion | pi+ | 80 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 573 | ||
| positive pion | pi+ | 80 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 80 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 80 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 80 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 597 | ||
| positive pion | pi+ | 80 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 80 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| positive pion | pi+ | 80 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| positive pion | pi+ | 80 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 80 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 80 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 689 | ||
| positive pion | pi+ | 80 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 80 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| positive pion | pi+ | 80 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| positive pion | pi+ | 80 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 80 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 627 | ||
| positive pion | pi+ | 80 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 615 | ||
| positive pion | pi+ | 80 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 622 | ||
| positive pion | pi+ | 80 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| positive pion | pi+ | 80 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 80 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 80 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 80 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 80 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| positive pion | pi+ | 80 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 80 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 80 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| positive pion | pi+ | 80 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 80 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 639 | ||
| positive pion | pi+ | 80 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.1 | |||
| positive pion | pi+ | 80 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| positive pion | pi+ | 80 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| positive pion | pi+ | 80 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 80 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| positive pion | pi+ | 80 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| positive pion | pi+ | 80 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 617 | ||
| positive pion | pi+ | 80 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 80 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 623 | ||
| positive pion | pi+ | 80 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| positive pion | pi+ | 80 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| positive pion | pi+ | 80 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 548 | ||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 551 | ||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 100 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 100 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| positive pion | pi+ | 100 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 100 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 515 | ||
| positive pion | pi+ | 100 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 100 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 100 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 100 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| positive pion | pi+ | 100 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 100 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 100 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 100 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 100 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 100 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 100 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 565 | ||
| positive pion | pi+ | 100 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 100 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 100 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 100 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 100 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 100 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| positive pion | pi+ | 100 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| positive pion | pi+ | 100 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 100 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 100 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 100 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| positive pion | pi+ | 100 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 100 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 100 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 100 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 100 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| positive pion | pi+ | 100 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 557 | ||
| positive pion | pi+ | 100 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| positive pion | pi+ | 100 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| positive pion | pi+ | 100 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 100 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 100 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 100 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 100 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 573 | ||
| positive pion | pi+ | 100 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 581 | ||
| positive pion | pi+ | 100 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 100 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| positive pion | pi+ | 100 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 100 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 100 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 556 | ||
| positive pion | pi+ | 100 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 100 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 100 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 100 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| positive pion | pi+ | 100 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 100 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| positive pion | pi+ | 100 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 100 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 100 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 595 | ||
| positive pion | pi+ | 100 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 100 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| positive pion | pi+ | 100 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| positive pion | pi+ | 100 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| positive pion | pi+ | 100 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| positive pion | pi+ | 100 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 100 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 100 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 100 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 100 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 519 | ||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 150 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 150 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 150 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 150 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 150 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 508 | ||
| positive pion | pi+ | 150 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 150 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 150 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| positive pion | pi+ | 150 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 150 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 150 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| positive pion | pi+ | 150 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| positive pion | pi+ | 150 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 150 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 150 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 150 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 150 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 150 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 150 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 150 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 150 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 150 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 150 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 150 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 150 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 150 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 150 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 150 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 513 | ||
| positive pion | pi+ | 150 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 150 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 150 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 150 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 150 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| positive pion | pi+ | 150 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 150 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 150 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| positive pion | pi+ | 150 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 150 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 150 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 150 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 150 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 150 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 150 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| positive pion | pi+ | 150 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 150 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 150 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 150 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| positive pion | pi+ | 150 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 150 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| positive pion | pi+ | 150 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 150 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 150 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 150 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 150 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 150 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 150 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 150 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 150 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 150 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 150 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 150 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 150 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 150 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 150 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 200 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 200 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| positive pion | pi+ | 200 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 200 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 200 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 200 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 200 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| positive pion | pi+ | 200 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 200 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 200 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 200 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 200 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 200 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 200 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 200 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 200 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 200 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 200 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 200 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 200 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 200 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 200 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 200 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 200 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 200 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 200 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 200 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 200 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 469 | ||
| positive pion | pi+ | 200 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 200 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 200 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 200 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 200 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 200 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 200 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| positive pion | pi+ | 200 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| positive pion | pi+ | 200 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 200 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 200 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| positive pion | pi+ | 200 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 200 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| positive pion | pi+ | 200 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 200 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 200 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 200 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 200 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 200 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 554 | ||
| positive pion | pi+ | 200 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 200 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 200 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| positive pion | pi+ | 200 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 200 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| positive pion | pi+ | 200 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 200 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 200 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 200 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 200 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| positive pion | pi+ | 200 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 200 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 200 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 502 | ||
| positive pion | pi+ | 200 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 200 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 502 | ||
| positive pion | pi+ | 200 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 200 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 513 | ||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 513 | ||
| positive pion | pi+ | 300 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 300 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 300 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 300 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| positive pion | pi+ | 300 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 300 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 300 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 300 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 300 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 300 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 509 | ||
| positive pion | pi+ | 300 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 300 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 | ||
| positive pion | pi+ | 300 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 300 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 300 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 300 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 300 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 300 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 300 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 300 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 300 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 300 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 300 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 300 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 300 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 519 | ||
| positive pion | pi+ | 300 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 300 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 300 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 300 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| positive pion | pi+ | 300 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 300 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 300 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 300 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 440 | ||
| positive pion | pi+ | 300 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| positive pion | pi+ | 300 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 300 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 513 | ||
| positive pion | pi+ | 300 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 300 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 508 | ||
| positive pion | pi+ | 300 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 | ||
| positive pion | pi+ | 300 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| positive pion | pi+ | 300 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| positive pion | pi+ | 300 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 300 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 300 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 300 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 300 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 300 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 300 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 300 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 300 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 | ||
| positive pion | pi+ | 300 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 300 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 300 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 300 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| positive pion | pi+ | 300 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 515 | ||
| positive pion | pi+ | 300 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 300 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 300 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 300 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 300 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 300 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 300 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 300 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 300 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 300 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 300 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 300 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 300 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 300 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 300 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 300 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 300 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 300 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 300 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 300 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 300 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 478 | ||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 475 | ||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 400 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 400 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 400 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 400 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 440 | ||
| positive pion | pi+ | 400 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 400 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 400 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 447 | ||
| positive pion | pi+ | 400 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| positive pion | pi+ | 400 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 400 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 400 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| positive pion | pi+ | 400 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 400 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 400 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 400 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| positive pion | pi+ | 400 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 493 | ||
| positive pion | pi+ | 400 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 400 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 400 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 400 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 400 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 400 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 400 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 400 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 461 | ||
| positive pion | pi+ | 400 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 459 | ||
| positive pion | pi+ | 400 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| positive pion | pi+ | 400 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| positive pion | pi+ | 400 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 400 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 454 | ||
| positive pion | pi+ | 400 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 418 | ||
| positive pion | pi+ | 400 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| positive pion | pi+ | 400 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 400 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 400 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 400 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 400 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| positive pion | pi+ | 400 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 400 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| positive pion | pi+ | 400 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 464 | ||
| positive pion | pi+ | 400 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 400 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| positive pion | pi+ | 400 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 400 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| positive pion | pi+ | 400 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 400 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 400 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 400 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 400 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 400 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 400 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| positive pion | pi+ | 400 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 464 | ||
| positive pion | pi+ | 400 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| positive pion | pi+ | 400 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 461 | ||
| positive pion | pi+ | 400 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| positive pion | pi+ | 400 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| positive pion | pi+ | 400 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 400 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| positive pion | pi+ | 400 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 494 | ||
| positive pion | pi+ | 400 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| positive pion | pi+ | 400 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| positive pion | pi+ | 400 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 400 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 400 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| positive pion | pi+ | 400 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| positive pion | pi+ | 400 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 400 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| positive pion | pi+ | 400 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 400 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| positive pion | pi+ | 400 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 400 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 465 | ||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 466 | ||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 464 | ||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 500 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 500 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 466 | ||
| positive pion | pi+ | 500 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 500 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 | ||
| positive pion | pi+ | 500 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 500 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 500 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 437 | ||
| positive pion | pi+ | 500 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| positive pion | pi+ | 500 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| positive pion | pi+ | 500 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| positive pion | pi+ | 500 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 464 | ||
| positive pion | pi+ | 500 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 500 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 469 | ||
| positive pion | pi+ | 500 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 500 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| positive pion | pi+ | 500 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 500 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 469 | ||
| positive pion | pi+ | 500 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 500 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 469 | ||
| positive pion | pi+ | 500 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 500 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 500 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| positive pion | pi+ | 500 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 464 | ||
| positive pion | pi+ | 500 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 500 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 | ||
| positive pion | pi+ | 500 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 450 | ||
| positive pion | pi+ | 500 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| positive pion | pi+ | 500 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 448 | ||
| positive pion | pi+ | 500 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 444 | ||
| positive pion | pi+ | 500 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 445 | ||
| positive pion | pi+ | 500 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 412 | ||
| positive pion | pi+ | 500 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 500 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 | ||
| positive pion | pi+ | 500 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 500 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| positive pion | pi+ | 500 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 500 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 478 | ||
| positive pion | pi+ | 500 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 500 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 500 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 500 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| positive pion | pi+ | 500 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 500 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| positive pion | pi+ | 500 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 500 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 500 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 500 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 500 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |||
| positive pion | pi+ | 500 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 500 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 500 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 500 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 500 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 500 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| positive pion | pi+ | 500 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 454 | ||
| positive pion | pi+ | 500 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 500 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 500 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 453 | ||
| positive pion | pi+ | 500 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 500 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 500 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 500 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| positive pion | pi+ | 500 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| positive pion | pi+ | 500 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 478 | ||
| positive pion | pi+ | 500 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 500 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 500 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 500 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 500 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 459 | ||
| positive pion | pi+ | 500 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 464 | ||
| positive pion | pi+ | 500 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 500 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 500 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| positive pion | pi+ | 500 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 500 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| positive pion | pi+ | 500 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 500 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 469 | ||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 468 | ||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| positive pion | pi+ | 600 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 600 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 600 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 600 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 | ||
| positive pion | pi+ | 600 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 600 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 439 | ||
| positive pion | pi+ | 600 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 600 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 600 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 600 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 600 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 600 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 473 | ||
| positive pion | pi+ | 600 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 459 | ||
| positive pion | pi+ | 600 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 600 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 600 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 600 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| positive pion | pi+ | 600 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 600 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 600 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| positive pion | pi+ | 600 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| positive pion | pi+ | 600 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 600 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 468 | ||
| positive pion | pi+ | 600 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 456 | ||
| positive pion | pi+ | 600 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 600 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 458 | ||
| positive pion | pi+ | 600 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 | ||
| positive pion | pi+ | 600 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| positive pion | pi+ | 600 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 448 | ||
| positive pion | pi+ | 600 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 415 | ||
| positive pion | pi+ | 600 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 411 | ||
| positive pion | pi+ | 600 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| positive pion | pi+ | 600 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| positive pion | pi+ | 600 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 600 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 600 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 493 | ||
| positive pion | pi+ | 600 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 600 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 | ||
| positive pion | pi+ | 600 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 600 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 600 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| positive pion | pi+ | 600 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 600 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 600 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| positive pion | pi+ | 600 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| positive pion | pi+ | 600 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 600 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| positive pion | pi+ | 600 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 600 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 600 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 459 | ||
| positive pion | pi+ | 600 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 459 | ||
| positive pion | pi+ | 600 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 600 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 455 | ||
| positive pion | pi+ | 600 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 600 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 486 | ||
| positive pion | pi+ | 600 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| positive pion | pi+ | 600 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 600 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 600 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 600 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 600 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 481 | ||
| positive pion | pi+ | 600 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| positive pion | pi+ | 600 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 600 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 463 | ||
| positive pion | pi+ | 600 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 600 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 469 | ||
| positive pion | pi+ | 600 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 600 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| positive pion | pi+ | 600 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 600 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 434 | ||
| positive pion | pi+ | 600 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 600 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 496 | ||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 498 | ||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 495 | ||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 800 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 800 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| positive pion | pi+ | 800 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 800 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 456 | ||
| positive pion | pi+ | 800 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 800 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 800 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 460 | ||
| positive pion | pi+ | 800 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 508 | ||
| positive pion | pi+ | 800 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 800 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| positive pion | pi+ | 800 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 498 | ||
| positive pion | pi+ | 800 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 800 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| positive pion | pi+ | 800 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 800 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 800 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 800 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| positive pion | pi+ | 800 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 800 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| positive pion | pi+ | 800 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 800 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 485 | ||
| positive pion | pi+ | 800 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 800 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 800 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 800 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 478 | ||
| positive pion | pi+ | 800 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| positive pion | pi+ | 800 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 472 | ||
| positive pion | pi+ | 800 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 474 | ||
| positive pion | pi+ | 800 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 471 | ||
| positive pion | pi+ | 800 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 433 | ||
| positive pion | pi+ | 800 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 427 | ||
| positive pion | pi+ | 800 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 800 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| positive pion | pi+ | 800 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 800 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 800 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 800 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 800 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 467 | ||
| positive pion | pi+ | 800 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 800 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 800 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 800 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 800 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 510 | ||
| positive pion | pi+ | 800 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| positive pion | pi+ | 800 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 | ||
| positive pion | pi+ | 800 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 800 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 503 | ||
| positive pion | pi+ | 800 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 497 | ||
| positive pion | pi+ | 800 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 483 | ||
| positive pion | pi+ | 800 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 800 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 476 | ||
| positive pion | pi+ | 800 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 800 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 800 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 514 | ||
| positive pion | pi+ | 800 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 800 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 517 | ||
| positive pion | pi+ | 800 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 513 | ||
| positive pion | pi+ | 800 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 509 | ||
| positive pion | pi+ | 800 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| positive pion | pi+ | 800 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 800 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 | ||
| positive pion | pi+ | 800 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 800 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 492 | ||
| positive pion | pi+ | 800 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 800 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| positive pion | pi+ | 800 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 800 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 444 | ||
| positive pion | pi+ | 800 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 800 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 444 | ||
| positive pion | pi+ | 800 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 800 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 1000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 525 | ||
| positive pion | pi+ | 1000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 475 | ||
| positive pion | pi+ | 1000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 1000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 1000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 480 | ||
| positive pion | pi+ | 1000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 538 | ||
| positive pion | pi+ | 1000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| positive pion | pi+ | 1000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 1000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 1000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 1000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 1000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 1000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.7 | |||
| positive pion | pi+ | 1000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| positive pion | pi+ | 1000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 1000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 1000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 1000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 1000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 1000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 1000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 1000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 1000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 | ||
| positive pion | pi+ | 1000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 | ||
| positive pion | pi+ | 1000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 500 | ||
| positive pion | pi+ | 1000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 498 | ||
| positive pion | pi+ | 1000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 490 | ||
| positive pion | pi+ | 1000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| positive pion | pi+ | 1000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| positive pion | pi+ | 1000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| positive pion | pi+ | 1000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 443 | ||
| positive pion | pi+ | 1000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 1000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 1000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| positive pion | pi+ | 1000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 1000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 482 | ||
| positive pion | pi+ | 1000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| positive pion | pi+ | 1000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 1000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 1000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 1000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 1000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 1000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 1000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 1000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 522 | ||
| positive pion | pi+ | 1000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| positive pion | pi+ | 1000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 507 | ||
| positive pion | pi+ | 1000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| positive pion | pi+ | 1000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 505 | ||
| positive pion | pi+ | 1000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 556 | ||
| positive pion | pi+ | 1000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 543 | ||
| positive pion | pi+ | 1000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 1000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 1000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 1000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 1000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 1000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 1000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 1000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 1000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 517 | ||
| positive pion | pi+ | 1000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 1000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| positive pion | pi+ | 1000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 449 | ||
| positive pion | pi+ | 1000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 565 | ||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 562 | ||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 1500 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1500 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| positive pion | pi+ | 1500 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 1500 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 504 | ||
| positive pion | pi+ | 1500 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 512 | ||
| positive pion | pi+ | 1500 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 1500 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 1500 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 579 | ||
| positive pion | pi+ | 1500 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 | ||
| positive pion | pi+ | 1500 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 594 | ||
| positive pion | pi+ | 1500 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 1500 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| positive pion | pi+ | 1500 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 1500 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 1500 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 1500 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 1500 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| positive pion | pi+ | 1500 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 578 | ||
| positive pion | pi+ | 1500 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 1500 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 1500 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 607 | ||
| positive pion | pi+ | 1500 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| positive pion | pi+ | 1500 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| positive pion | pi+ | 1500 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 1500 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 1500 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 526 | ||
| positive pion | pi+ | 1500 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 1500 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 533 | ||
| positive pion | pi+ | 1500 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 1500 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 470 | ||
| positive pion | pi+ | 1500 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 1500 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| positive pion | pi+ | 1500 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| positive pion | pi+ | 1500 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| positive pion | pi+ | 1500 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 518 | ||
| positive pion | pi+ | 1500 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 1500 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 596 | ||
| positive pion | pi+ | 1500 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| positive pion | pi+ | 1500 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 1500 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 573 | ||
| positive pion | pi+ | 1500 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| positive pion | pi+ | 1500 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 1500 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| positive pion | pi+ | 1500 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 1500 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 1500 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 1500 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 1500 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 539 | ||
| positive pion | pi+ | 1500 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 1500 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 1500 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 1500 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 1500 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 594 | ||
| positive pion | pi+ | 1500 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 592 | ||
| positive pion | pi+ | 1500 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| positive pion | pi+ | 1500 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| positive pion | pi+ | 1500 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 | ||
| positive pion | pi+ | 1500 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 1500 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| positive pion | pi+ | 1500 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 1500 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 1500 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 1500 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| positive pion | pi+ | 1500 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 1500 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 462 | ||
| positive pion | pi+ | 1500 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 1500 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 583 | ||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 2000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 2000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 583 | ||
| positive pion | pi+ | 2000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 2000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 516 | ||
| positive pion | pi+ | 2000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 2000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 523 | ||
| positive pion | pi+ | 2000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| positive pion | pi+ | 2000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| positive pion | pi+ | 2000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 2000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 2000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 609 | ||
| positive pion | pi+ | 2000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 2000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 2000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 615 | ||
| positive pion | pi+ | 2000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 608 | ||
| positive pion | pi+ | 2000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 2000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| positive pion | pi+ | 2000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| positive pion | pi+ | 2000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 2000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 540 | ||
| positive pion | pi+ | 2000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 632 | ||
| positive pion | pi+ | 2000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 596 | ||
| positive pion | pi+ | 2000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 2000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 2000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 2000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 2000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 2000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 529 | ||
| positive pion | pi+ | 2000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 2000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 488 | ||
| positive pion | pi+ | 2000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 479 | ||
| positive pion | pi+ | 2000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 595 | ||
| positive pion | pi+ | 2000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| positive pion | pi+ | 2000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 619 | ||
| positive pion | pi+ | 2000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 2000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 532 | ||
| positive pion | pi+ | 2000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 2000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 546 | ||
| positive pion | pi+ | 2000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| positive pion | pi+ | 2000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| positive pion | pi+ | 2000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 602 | ||
| positive pion | pi+ | 2000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| positive pion | pi+ | 2000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 2000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 607 | ||
| positive pion | pi+ | 2000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 591 | ||
| positive pion | pi+ | 2000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 2000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 558 | ||
| positive pion | pi+ | 2000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 2000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 560 | ||
| positive pion | pi+ | 2000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 541 | ||
| positive pion | pi+ | 2000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| positive pion | pi+ | 2000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 608 | ||
| positive pion | pi+ | 2000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| positive pion | pi+ | 2000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 2000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 620 | ||
| positive pion | pi+ | 2000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 2000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 603 | ||
| positive pion | pi+ | 2000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| positive pion | pi+ | 2000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 2000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| positive pion | pi+ | 2000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| positive pion | pi+ | 2000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 2000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 2000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 2000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 2000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 2000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 489 | ||
| positive pion | pi+ | 2000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 2000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 579 | ||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 583 | ||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 3000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 3000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 577 | ||
| positive pion | pi+ | 3000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 3000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 3000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 520 | ||
| positive pion | pi+ | 3000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 602 | ||
| positive pion | pi+ | 3000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 596 | ||
| positive pion | pi+ | 3000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| positive pion | pi+ | 3000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 | ||
| positive pion | pi+ | 3000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| positive pion | pi+ | 3000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 582 | ||
| positive pion | pi+ | 3000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 573 | ||
| positive pion | pi+ | 3000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| positive pion | pi+ | 3000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 3000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 607 | ||
| positive pion | pi+ | 3000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 583 | ||
| positive pion | pi+ | 3000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| positive pion | pi+ | 3000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 3000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 3000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 3000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 627 | ||
| positive pion | pi+ | 3000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 3000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 547 | ||
| positive pion | pi+ | 3000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 3000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 3000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 3000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 3000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 3000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 487 | ||
| positive pion | pi+ | 3000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 477 | ||
| positive pion | pi+ | 3000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 595 | ||
| positive pion | pi+ | 3000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 3000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| positive pion | pi+ | 3000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 602 | ||
| positive pion | pi+ | 3000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 521 | ||
| positive pion | pi+ | 3000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 3000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 619 | ||
| positive pion | pi+ | 3000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 3000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 592 | ||
| positive pion | pi+ | 3000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| positive pion | pi+ | 3000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| positive pion | pi+ | 3000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| positive pion | pi+ | 3000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| positive pion | pi+ | 3000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 590 | ||
| positive pion | pi+ | 3000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 578 | ||
| positive pion | pi+ | 3000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| positive pion | pi+ | 3000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 552 | ||
| positive pion | pi+ | 3000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 556 | ||
| positive pion | pi+ | 3000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 3000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 | ||
| positive pion | pi+ | 3000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 3000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 3000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| positive pion | pi+ | 3000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 3000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 614 | ||
| positive pion | pi+ | 3000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 602 | ||
| positive pion | pi+ | 3000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 3000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 3000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 3000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 3000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 573 | ||
| positive pion | pi+ | 3000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 570 | ||
| positive pion | pi+ | 3000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 3000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 3000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| positive pion | pi+ | 3000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 3000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 496 | ||
| positive pion | pi+ | 3000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 3000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 595 | ||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 4000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 4000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 | ||
| positive pion | pi+ | 4000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 4000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 534 | ||
| positive pion | pi+ | 4000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 527 | ||
| positive pion | pi+ | 4000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 616 | ||
| positive pion | pi+ | 4000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 605 | ||
| positive pion | pi+ | 4000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 4000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| positive pion | pi+ | 4000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 625 | ||
| positive pion | pi+ | 4000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 4000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 576 | ||
| positive pion | pi+ | 4000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| positive pion | pi+ | 4000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 4000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 619 | ||
| positive pion | pi+ | 4000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 594 | ||
| positive pion | pi+ | 4000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| positive pion | pi+ | 4000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| positive pion | pi+ | 4000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 4000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 4000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 642 | ||
| positive pion | pi+ | 4000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 4000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| positive pion | pi+ | 4000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 548 | ||
| positive pion | pi+ | 4000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 4000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 4000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 528 | ||
| positive pion | pi+ | 4000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 535 | ||
| positive pion | pi+ | 4000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 495 | ||
| positive pion | pi+ | 4000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 4000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 484 | ||
| positive pion | pi+ | 4000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 4000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 4000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 4000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 642 | ||
| positive pion | pi+ | 4000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 607 | ||
| positive pion | pi+ | 4000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 524 | ||
| positive pion | pi+ | 4000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 536 | ||
| positive pion | pi+ | 4000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 636 | ||
| positive pion | pi+ | 4000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 4000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 611 | ||
| positive pion | pi+ | 4000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 4000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 4000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 | ||
| positive pion | pi+ | 4000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 608 | ||
| positive pion | pi+ | 4000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 4000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 588 | ||
| positive pion | pi+ | 4000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 4000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 559 | ||
| positive pion | pi+ | 4000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 555 | ||
| positive pion | pi+ | 4000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 4000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 650 | ||
| positive pion | pi+ | 4000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 618 | ||
| positive pion | pi+ | 4000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| positive pion | pi+ | 4000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 625 | ||
| positive pion | pi+ | 4000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| positive pion | pi+ | 4000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 616 | ||
| positive pion | pi+ | 4000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 614 | ||
| positive pion | pi+ | 4000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 4000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 4000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 584 | ||
| positive pion | pi+ | 4000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 4000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 4000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 4000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 4000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 4000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 4000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 491 | ||
| positive pion | pi+ | 4000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 4000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 619 | ||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 607 | ||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 5000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 632 | ||
| positive pion | pi+ | 5000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 5000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 5000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 5000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 550 | ||
| positive pion | pi+ | 5000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 5000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 5000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 644 | ||
| positive pion | pi+ | 5000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| positive pion | pi+ | 5000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| positive pion | pi+ | 5000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 597 | ||
| positive pion | pi+ | 5000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 652 | ||
| positive pion | pi+ | 5000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 | ||
| positive pion | pi+ | 5000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 5000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 594 | ||
| positive pion | pi+ | 5000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 5000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 648 | ||
| positive pion | pi+ | 5000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 648 | ||
| positive pion | pi+ | 5000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 619 | ||
| positive pion | pi+ | 5000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 640 | ||
| positive pion | pi+ | 5000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 | ||
| positive pion | pi+ | 5000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 5000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 5000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 674 | ||
| positive pion | pi+ | 5000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 631 | ||
| positive pion | pi+ | 5000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 575 | ||
| positive pion | pi+ | 5000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 5000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 | ||
| positive pion | pi+ | 5000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 5000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 544 | ||
| positive pion | pi+ | 5000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 5000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 551 | ||
| positive pion | pi+ | 5000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 5000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 511 | ||
| positive pion | pi+ | 5000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 | ||
| positive pion | pi+ | 5000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 631 | ||
| positive pion | pi+ | 5000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 5000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 672 | ||
| positive pion | pi+ | 5000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 5000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| positive pion | pi+ | 5000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 5000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 542 | ||
| positive pion | pi+ | 5000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 549 | ||
| positive pion | pi+ | 5000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 664 | ||
| positive pion | pi+ | 5000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| positive pion | pi+ | 5000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 638 | ||
| positive pion | pi+ | 5000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 608 | ||
| positive pion | pi+ | 5000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 661 | ||
| positive pion | pi+ | 5000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 634 | ||
| positive pion | pi+ | 5000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 631 | ||
| positive pion | pi+ | 5000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 5000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 586 | ||
| positive pion | pi+ | 5000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 5000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| positive pion | pi+ | 5000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 5000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| positive pion | pi+ | 5000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 5000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 646 | ||
| positive pion | pi+ | 5000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| positive pion | pi+ | 5000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 5000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 655 | ||
| positive pion | pi+ | 5000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 660 | ||
| positive pion | pi+ | 5000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| positive pion | pi+ | 5000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 640 | ||
| positive pion | pi+ | 5000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 614 | ||
| positive pion | pi+ | 5000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 5000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 608 | ||
| positive pion | pi+ | 5000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 580 | ||
| positive pion | pi+ | 5000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 5000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| positive pion | pi+ | 5000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 5000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 506 | ||
| positive pion | pi+ | 5000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 5000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 640 | ||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 647 | ||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 634 | ||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 662 | ||
| positive pion | pi+ | 6000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 6000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 640 | ||
| positive pion | pi+ | 6000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 6000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 568 | ||
| positive pion | pi+ | 6000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 567 | ||
| positive pion | pi+ | 6000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 676 | ||
| positive pion | pi+ | 6000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 659 | ||
| positive pion | pi+ | 6000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 649 | ||
| positive pion | pi+ | 6000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| positive pion | pi+ | 6000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| positive pion | pi+ | 6000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 653 | ||
| positive pion | pi+ | 6000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| positive pion | pi+ | 6000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| positive pion | pi+ | 6000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 681 | ||
| positive pion | pi+ | 6000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 648 | ||
| positive pion | pi+ | 6000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 671 | ||
| positive pion | pi+ | 6000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 652 | ||
| positive pion | pi+ | 6000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 6000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 6000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 6000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 6000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 709 | ||
| positive pion | pi+ | 6000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 663 | ||
| positive pion | pi+ | 6000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 599 | ||
| positive pion | pi+ | 6000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 589 | ||
| positive pion | pi+ | 6000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 574 | ||
| positive pion | pi+ | 6000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 561 | ||
| positive pion | pi+ | 6000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 566 | ||
| positive pion | pi+ | 6000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 572 | ||
| positive pion | pi+ | 6000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 | ||
| positive pion | pi+ | 6000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 517 | ||
| positive pion | pi+ | 6000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 661 | ||
| positive pion | pi+ | 6000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 642 | ||
| positive pion | pi+ | 6000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 705 | ||
| positive pion | pi+ | 6000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 674 | ||
| positive pion | pi+ | 6000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 6000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 565 | ||
| positive pion | pi+ | 6000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 569 | ||
| positive pion | pi+ | 6000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 6000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 696 | ||
| positive pion | pi+ | 6000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| positive pion | pi+ | 6000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 668 | ||
| positive pion | pi+ | 6000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 636 | ||
| positive pion | pi+ | 6000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 695 | ||
| positive pion | pi+ | 6000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 665 | ||
| positive pion | pi+ | 6000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 660 | ||
| positive pion | pi+ | 6000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 638 | ||
| positive pion | pi+ | 6000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 612 | ||
| positive pion | pi+ | 6000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 6000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 595 | ||
| positive pion | pi+ | 6000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 585 | ||
| positive pion | pi+ | 6000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 717 | ||
| positive pion | pi+ | 6000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 6000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 677 | ||
| positive pion | pi+ | 6000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 688 | ||
| positive pion | pi+ | 6000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 691 | ||
| positive pion | pi+ | 6000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 694 | ||
| positive pion | pi+ | 6000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 673 | ||
| positive pion | pi+ | 6000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 6000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 671 | ||
| positive pion | pi+ | 6000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| positive pion | pi+ | 6000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 | ||
| positive pion | pi+ | 6000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 6000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 6000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 601 | ||
| positive pion | pi+ | 6000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 6000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 6000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 531 | ||
| positive pion | pi+ | 6000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 6000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 686 | ||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 694 | ||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 677 | ||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 714 | ||
| positive pion | pi+ | 8000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 8000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| positive pion | pi+ | 8000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 8000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 603 | ||
| positive pion | pi+ | 8000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 8000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 604 | ||
| positive pion | pi+ | 8000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 726 | ||
| positive pion | pi+ | 8000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 708 | ||
| positive pion | pi+ | 8000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 696 | ||
| positive pion | pi+ | 8000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 662 | ||
| positive pion | pi+ | 8000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 730 | ||
| positive pion | pi+ | 8000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 692 | ||
| positive pion | pi+ | 8000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 681 | ||
| positive pion | pi+ | 8000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 748 | ||
| positive pion | pi+ | 8000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 733 | ||
| positive pion | pi+ | 8000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 694 | ||
| positive pion | pi+ | 8000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 720 | ||
| positive pion | pi+ | 8000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 689 | ||
| positive pion | pi+ | 8000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| positive pion | pi+ | 8000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 8000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 628 | ||
| positive pion | pi+ | 8000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 8000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 762 | ||
| positive pion | pi+ | 8000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 716 | ||
| positive pion | pi+ | 8000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 640 | ||
| positive pion | pi+ | 8000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 626 | ||
| positive pion | pi+ | 8000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 613 | ||
| positive pion | pi+ | 8000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 593 | ||
| positive pion | pi+ | 8000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 8000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 8000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 606 | ||
| positive pion | pi+ | 8000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 8000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 562 | ||
| positive pion | pi+ | 8000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 | ||
| positive pion | pi+ | 8000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 714 | ||
| positive pion | pi+ | 8000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 690 | ||
| positive pion | pi+ | 8000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 755 | ||
| positive pion | pi+ | 8000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 730 | ||
| positive pion | pi+ | 8000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 603 | ||
| positive pion | pi+ | 8000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 610 | ||
| positive pion | pi+ | 8000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 759 | ||
| positive pion | pi+ | 8000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 740 | ||
| positive pion | pi+ | 8000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 716 | ||
| positive pion | pi+ | 8000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 683 | ||
| positive pion | pi+ | 8000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 752 | ||
| positive pion | pi+ | 8000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 | ||
| positive pion | pi+ | 8000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 709 | ||
| positive pion | pi+ | 8000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 681 | ||
| positive pion | pi+ | 8000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 654 | ||
| positive pion | pi+ | 8000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 644 | ||
| positive pion | pi+ | 8000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 | ||
| positive pion | pi+ | 8000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 616 | ||
| positive pion | pi+ | 8000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 772 | ||
| positive pion | pi+ | 8000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 728 | ||
| positive pion | pi+ | 8000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 778 | ||
| positive pion | pi+ | 8000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 752 | ||
| positive pion | pi+ | 8000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 752 | ||
| positive pion | pi+ | 8000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 725 | ||
| positive pion | pi+ | 8000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 722 | ||
| positive pion | pi+ | 8000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 693 | ||
| positive pion | pi+ | 8000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 678 | ||
| positive pion | pi+ | 8000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 8000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 8000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 644 | ||
| positive pion | pi+ | 8000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 8000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| positive pion | pi+ | 8000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 8000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 571 | ||
| positive pion | pi+ | 8000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 8000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 717 | ||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 728 | ||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 706 | ||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| positive pion | pi+ | 10000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 713 | ||
| positive pion | pi+ | 10000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 10000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 634 | ||
| positive pion | pi+ | 10000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 629 | ||
| positive pion | pi+ | 10000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 761 | ||
| positive pion | pi+ | 10000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 739 | ||
| positive pion | pi+ | 10000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 729 | ||
| positive pion | pi+ | 10000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 690 | ||
| positive pion | pi+ | 10000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 765 | ||
| positive pion | pi+ | 10000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 | ||
| positive pion | pi+ | 10000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 719 | ||
| positive pion | pi+ | 10000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 786 | ||
| positive pion | pi+ | 10000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 767 | ||
| positive pion | pi+ | 10000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 727 | ||
| positive pion | pi+ | 10000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 754 | ||
| positive pion | pi+ | 10000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 718 | ||
| positive pion | pi+ | 10000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| positive pion | pi+ | 10000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 10000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 643 | ||
| positive pion | pi+ | 10000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 10000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| positive pion | pi+ | 10000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 10000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 747 | ||
| positive pion | pi+ | 10000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 10000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 668 | ||
| positive pion | pi+ | 10000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 651 | ||
| positive pion | pi+ | 10000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 637 | ||
| positive pion | pi+ | 10000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 614 | ||
| positive pion | pi+ | 10000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 633 | ||
| positive pion | pi+ | 10000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 624 | ||
| positive pion | pi+ | 10000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 583 | ||
| positive pion | pi+ | 10000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 564 | ||
| positive pion | pi+ | 10000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 750 | ||
| positive pion | pi+ | 10000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 722 | ||
| positive pion | pi+ | 10000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 786 | ||
| positive pion | pi+ | 10000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 760 | ||
| positive pion | pi+ | 10000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 623 | ||
| positive pion | pi+ | 10000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 639 | ||
| positive pion | pi+ | 10000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 10000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 800 | ||
| positive pion | pi+ | 10000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 10000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 777 | ||
| positive pion | pi+ | 10000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 10000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 752 | ||
| positive pion | pi+ | 10000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 715 | ||
| positive pion | pi+ | 10000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 791 | ||
| positive pion | pi+ | 10000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 758 | ||
| positive pion | pi+ | 10000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 742 | ||
| positive pion | pi+ | 10000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 710 | ||
| positive pion | pi+ | 10000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 684 | ||
| positive pion | pi+ | 10000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 671 | ||
| positive pion | pi+ | 10000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 656 | ||
| positive pion | pi+ | 10000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 641 | ||
| positive pion | pi+ | 10000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 812 | ||
| positive pion | pi+ | 10000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 762 | ||
| positive pion | pi+ | 10000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 10000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 835 | ||
| positive pion | pi+ | 10000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 789 | ||
| positive pion | pi+ | 10000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 10000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| positive pion | pi+ | 10000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 762 | ||
| positive pion | pi+ | 10000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 760 | ||
| positive pion | pi+ | 10000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 727 | ||
| positive pion | pi+ | 10000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 10000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 713 | ||
| positive pion | pi+ | 10000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 670 | ||
| positive pion | pi+ | 10000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 10000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 10000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 10000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 598 | ||
| positive pion | pi+ | 10000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 10000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 775 | ||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 787 | ||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 763 | ||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 812 | ||
| positive pion | pi+ | 15000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 773 | ||
| positive pion | pi+ | 15000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 15000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 689 | ||
| positive pion | pi+ | 15000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 668 | ||
| positive pion | pi+ | 15000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 828 | ||
| positive pion | pi+ | 15000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 805 | ||
| positive pion | pi+ | 15000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 785 | ||
| positive pion | pi+ | 15000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 739 | ||
| positive pion | pi+ | 15000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 829 | ||
| positive pion | pi+ | 15000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 781 | ||
| positive pion | pi+ | 15000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 767 | ||
| positive pion | pi+ | 15000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 15000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 864 | ||
| positive pion | pi+ | 15000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 832 | ||
| positive pion | pi+ | 15000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 786 | ||
| positive pion | pi+ | 15000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 816 | ||
| positive pion | pi+ | 15000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 15000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 763 | ||
| positive pion | pi+ | 15000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 15000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 701 | ||
| positive pion | pi+ | 15000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 15000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 701 | ||
| positive pion | pi+ | 15000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 15000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 873 | ||
| positive pion | pi+ | 15000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 811 | ||
| positive pion | pi+ | 15000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 716 | ||
| positive pion | pi+ | 15000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 699 | ||
| positive pion | pi+ | 15000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| positive pion | pi+ | 15000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 648 | ||
| positive pion | pi+ | 15000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 663 | ||
| positive pion | pi+ | 15000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 667 | ||
| positive pion | pi+ | 15000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 621 | ||
| positive pion | pi+ | 15000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 600 | ||
| positive pion | pi+ | 15000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 808 | ||
| positive pion | pi+ | 15000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 776 | ||
| positive pion | pi+ | 15000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 849 | ||
| positive pion | pi+ | 15000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 818 | ||
| positive pion | pi+ | 15000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 661 | ||
| positive pion | pi+ | 15000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 687 | ||
| positive pion | pi+ | 15000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 852 | ||
| positive pion | pi+ | 15000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 15000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 836 | ||
| positive pion | pi+ | 15000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 816 | ||
| positive pion | pi+ | 15000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 761 | ||
| positive pion | pi+ | 15000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 15000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 859 | ||
| positive pion | pi+ | 15000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 15000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 804 | ||
| positive pion | pi+ | 15000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 767 | ||
| positive pion | pi+ | 15000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 735 | ||
| positive pion | pi+ | 15000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 | ||
| positive pion | pi+ | 15000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 702 | ||
| positive pion | pi+ | 15000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 687 | ||
| positive pion | pi+ | 15000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 882 | ||
| positive pion | pi+ | 15000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 827 | ||
| positive pion | pi+ | 15000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| positive pion | pi+ | 15000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 849 | ||
| positive pion | pi+ | 15000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 15000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 853 | ||
| positive pion | pi+ | 15000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 825 | ||
| positive pion | pi+ | 15000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 830 | ||
| positive pion | pi+ | 15000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 770 | ||
| positive pion | pi+ | 15000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 15000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 762 | ||
| positive pion | pi+ | 15000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 721 | ||
| positive pion | pi+ | 15000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 15000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 15000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| positive pion | pi+ | 15000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 15000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 630 | ||
| positive pion | pi+ | 15000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 15000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 822 | ||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 836 | ||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 808 | ||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 863 | ||
| positive pion | pi+ | 20000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 20000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 20000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 737 | ||
| positive pion | pi+ | 20000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 695 | ||
| positive pion | pi+ | 20000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 881 | ||
| positive pion | pi+ | 20000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 864 | ||
| positive pion | pi+ | 20000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 829 | ||
| positive pion | pi+ | 20000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 774 | ||
| positive pion | pi+ | 20000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 870 | ||
| positive pion | pi+ | 20000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 825 | ||
| positive pion | pi+ | 20000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 20000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 20000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 932 | ||
| positive pion | pi+ | 20000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 20000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 884 | ||
| positive pion | pi+ | 20000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 830 | ||
| positive pion | pi+ | 20000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 866 | ||
| positive pion | pi+ | 20000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 795 | ||
| positive pion | pi+ | 20000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 747 | ||
| positive pion | pi+ | 20000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 20000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 747 | ||
| positive pion | pi+ | 20000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 20000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 941 | ||
| positive pion | pi+ | 20000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 872 | ||
| positive pion | pi+ | 20000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 756 | ||
| positive pion | pi+ | 20000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 739 | ||
| positive pion | pi+ | 20000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 705 | ||
| positive pion | pi+ | 20000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 675 | ||
| positive pion | pi+ | 20000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 686 | ||
| positive pion | pi+ | 20000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 702 | ||
| positive pion | pi+ | 20000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 653 | ||
| positive pion | pi+ | 20000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 627 | ||
| positive pion | pi+ | 20000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 855 | ||
| positive pion | pi+ | 20000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 822 | ||
| positive pion | pi+ | 20000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 901 | ||
| positive pion | pi+ | 20000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 867 | ||
| positive pion | pi+ | 20000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 694 | ||
| positive pion | pi+ | 20000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 727 | ||
| positive pion | pi+ | 20000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 890 | ||
| positive pion | pi+ | 20000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 890 | ||
| positive pion | pi+ | 20000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 862 | ||
| positive pion | pi+ | 20000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 787 | ||
| positive pion | pi+ | 20000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 20000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 907 | ||
| positive pion | pi+ | 20000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 873 | ||
| positive pion | pi+ | 20000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 856 | ||
| positive pion | pi+ | 20000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 815 | ||
| positive pion | pi+ | 20000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 776 | ||
| positive pion | pi+ | 20000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 762 | ||
| positive pion | pi+ | 20000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 747 | ||
| positive pion | pi+ | 20000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 713 | ||
| positive pion | pi+ | 20000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 926 | ||
| positive pion | pi+ | 20000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 895 | ||
| positive pion | pi+ | 20000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 965 | ||
| positive pion | pi+ | 20000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 918 | ||
| positive pion | pi+ | 20000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 20000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 909 | ||
| positive pion | pi+ | 20000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 877 | ||
| positive pion | pi+ | 20000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 20000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 877 | ||
| positive pion | pi+ | 20000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 807 | ||
| positive pion | pi+ | 20000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 20000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 800 | ||
| positive pion | pi+ | 20000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 751 | ||
| positive pion | pi+ | 20000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 20000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 20000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| positive pion | pi+ | 20000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 20000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 647 | ||
| positive pion | pi+ | 20000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 20000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 894 | ||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 912 | ||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 875 | ||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 950 | ||
| positive pion | pi+ | 30000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 891 | ||
| positive pion | pi+ | 30000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 30000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 781 | ||
| positive pion | pi+ | 30000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 744 | ||
| positive pion | pi+ | 30000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 30000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 967 | ||
| positive pion | pi+ | 30000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 938 | ||
| positive pion | pi+ | 30000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| positive pion | pi+ | 30000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 837 | ||
| positive pion | pi+ | 30000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 967 | ||
| positive pion | pi+ | 30000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| positive pion | pi+ | 30000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 898 | ||
| positive pion | pi+ | 30000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 30000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 30000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 967 | ||
| positive pion | pi+ | 30000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 896 | ||
| positive pion | pi+ | 30000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 953 | ||
| positive pion | pi+ | 30000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 859 | ||
| positive pion | pi+ | 30000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 805 | ||
| positive pion | pi+ | 30000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 805 | ||
| positive pion | pi+ | 30000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| positive pion | pi+ | 30000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 947 | ||
| positive pion | pi+ | 30000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 30000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 797 | ||
| positive pion | pi+ | 30000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 754 | ||
| positive pion | pi+ | 30000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 719 | ||
| positive pion | pi+ | 30000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 753 | ||
| positive pion | pi+ | 30000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 742 | ||
| positive pion | pi+ | 30000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 706 | ||
| positive pion | pi+ | 30000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 672 | ||
| positive pion | pi+ | 30000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 935 | ||
| positive pion | pi+ | 30000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 892 | ||
| positive pion | pi+ | 30000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| positive pion | pi+ | 30000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 949 | ||
| positive pion | pi+ | 30000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 738 | ||
| positive pion | pi+ | 30000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 764 | ||
| positive pion | pi+ | 30000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 974 | ||
| positive pion | pi+ | 30000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 974 | ||
| positive pion | pi+ | 30000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 30000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 943 | ||
| positive pion | pi+ | 30000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 853 | ||
| positive pion | pi+ | 30000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| positive pion | pi+ | 30000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 950 | ||
| positive pion | pi+ | 30000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 939 | ||
| positive pion | pi+ | 30000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 886 | ||
| positive pion | pi+ | 30000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 847 | ||
| positive pion | pi+ | 30000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 824 | ||
| positive pion | pi+ | 30000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 791 | ||
| positive pion | pi+ | 30000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 752 | ||
| positive pion | pi+ | 30000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 30000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 974 | ||
| positive pion | pi+ | 30000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 30000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 30000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 30000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 30000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 961 | ||
| positive pion | pi+ | 30000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 963 | ||
| positive pion | pi+ | 30000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 888 | ||
| positive pion | pi+ | 30000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 30000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 30000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 882 | ||
| positive pion | pi+ | 30000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 30000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 807 | ||
| positive pion | pi+ | 30000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 30000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| positive pion | pi+ | 30000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 30000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 682 | ||
| positive pion | pi+ | 30000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 30000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 953 | ||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 976 | ||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 930 | ||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 40000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 40000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 944 | ||
| positive pion | pi+ | 40000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 40000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 825 | ||
| positive pion | pi+ | 40000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 789 | ||
| positive pion | pi+ | 40000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 40000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 40000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 957 | ||
| positive pion | pi+ | 40000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 889 | ||
| positive pion | pi+ | 40000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 40000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 962 | ||
| positive pion | pi+ | 40000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 40000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 946 | ||
| positive pion | pi+ | 40000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 40000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 40000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 40000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 40000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 954 | ||
| positive pion | pi+ | 40000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 40000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 913 | ||
| positive pion | pi+ | 40000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 849 | ||
| positive pion | pi+ | 40000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 849 | ||
| positive pion | pi+ | 40000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 40000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 40000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| positive pion | pi+ | 40000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 875 | ||
| positive pion | pi+ | 40000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 843 | ||
| positive pion | pi+ | 40000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| positive pion | pi+ | 40000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 762 | ||
| positive pion | pi+ | 40000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 803 | ||
| positive pion | pi+ | 40000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 783 | ||
| positive pion | pi+ | 40000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 748 | ||
| positive pion | pi+ | 40000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 709 | ||
| positive pion | pi+ | 40000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 40000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 949 | ||
| positive pion | pi+ | 40000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 40000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 40000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 780 | ||
| positive pion | pi+ | 40000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| positive pion | pi+ | 40000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |||
| positive pion | pi+ | 40000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 40000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 40000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 40000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 914 | ||
| positive pion | pi+ | 40000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 40000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 40000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| positive pion | pi+ | 40000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 40000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 945 | ||
| positive pion | pi+ | 40000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 40000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 904 | ||
| positive pion | pi+ | 40000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 875 | ||
| positive pion | pi+ | 40000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 837 | ||
| positive pion | pi+ | 40000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 801 | ||
| positive pion | pi+ | 40000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 40000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 40000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| positive pion | pi+ | 40000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 40000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 40000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| positive pion | pi+ | 40000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| positive pion | pi+ | 40000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| positive pion | pi+ | 40000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 40000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 945 | ||
| positive pion | pi+ | 40000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 946 | ||
| positive pion | pi+ | 40000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 40000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 864 | ||
| positive pion | pi+ | 40000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 40000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 713 | ||
| positive pion | pi+ | 40000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 40000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 713 | ||
| positive pion | pi+ | 40000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 40000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1000 | ||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1030 | ||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 977 | ||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 50000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 50000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 993 | ||
| positive pion | pi+ | 50000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 50000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 866 | ||
| positive pion | pi+ | 50000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 828 | ||
| positive pion | pi+ | 50000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 50000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 50000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 50000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 931 | ||
| positive pion | pi+ | 50000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 50000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 50000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 993 | ||
| positive pion | pi+ | 50000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 50000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 50000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 50000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 50000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 50000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 963 | ||
| positive pion | pi+ | 50000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 50000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 887 | ||
| positive pion | pi+ | 50000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 887 | ||
| positive pion | pi+ | 50000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 50000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 50000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 920 | ||
| positive pion | pi+ | 50000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 883 | ||
| positive pion | pi+ | 50000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 827 | ||
| positive pion | pi+ | 50000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 798 | ||
| positive pion | pi+ | 50000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 840 | ||
| positive pion | pi+ | 50000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 824 | ||
| positive pion | pi+ | 50000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 786 | ||
| positive pion | pi+ | 50000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 742 | ||
| positive pion | pi+ | 50000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 | ||
| positive pion | pi+ | 50000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 998 | ||
| positive pion | pi+ | 50000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 50000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 50000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 819 | ||
| positive pion | pi+ | 50000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 50000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 50000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 50000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| positive pion | pi+ | 50000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 50000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 50000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 968 | ||
| positive pion | pi+ | 50000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 50000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 50000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 50000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 50000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 995 | ||
| positive pion | pi+ | 50000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 50000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 954 | ||
| positive pion | pi+ | 50000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 920 | ||
| positive pion | pi+ | 50000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 879 | ||
| positive pion | pi+ | 50000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 847 | ||
| positive pion | pi+ | 50000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| positive pion | pi+ | 50000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 50000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| positive pion | pi+ | 50000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 50000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 50000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| positive pion | pi+ | 50000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| positive pion | pi+ | 50000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 50000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 50000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 992 | ||
| positive pion | pi+ | 50000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 989 | ||
| positive pion | pi+ | 50000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 50000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 916 | ||
| positive pion | pi+ | 50000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 50000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 743 | ||
| positive pion | pi+ | 50000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 50000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 743 | ||
| positive pion | pi+ | 50000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 50000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1080 | ||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 60000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 60000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 60000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 60000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 901 | ||
| positive pion | pi+ | 60000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 863 | ||
| positive pion | pi+ | 60000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 60000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 60000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 60000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 968 | ||
| positive pion | pi+ | 60000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 60000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 60000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 60000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 60000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 60000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 60000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 60000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 60000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 60000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 60000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 924 | ||
| positive pion | pi+ | 60000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 924 | ||
| positive pion | pi+ | 60000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| positive pion | pi+ | 60000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 60000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 60000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 963 | ||
| positive pion | pi+ | 60000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 920 | ||
| positive pion | pi+ | 60000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 861 | ||
| positive pion | pi+ | 60000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 827 | ||
| positive pion | pi+ | 60000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 872 | ||
| positive pion | pi+ | 60000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 860 | ||
| positive pion | pi+ | 60000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 819 | ||
| positive pion | pi+ | 60000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 771 | ||
| positive pion | pi+ | 60000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 60000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 60000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| positive pion | pi+ | 60000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1170 | ||
| positive pion | pi+ | 60000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 854 | ||
| positive pion | pi+ | 60000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 858 | ||
| positive pion | pi+ | 60000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 60000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| positive pion | pi+ | 60000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 60000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 60000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 60000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| positive pion | pi+ | 60000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 60000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 60000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 60000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 60000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 60000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 | ||
| positive pion | pi+ | 60000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 961 | ||
| positive pion | pi+ | 60000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 914 | ||
| positive pion | pi+ | 60000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 884 | ||
| positive pion | pi+ | 60000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| positive pion | pi+ | 60000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 60000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 60000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 60000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 60000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 60000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| positive pion | pi+ | 60000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 60000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 60000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 60000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 963 | ||
| positive pion | pi+ | 60000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 60000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 60000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 763 | ||
| positive pion | pi+ | 60000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 60000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 763 | ||
| positive pion | pi+ | 60000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 60000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1170 | ||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| positive pion | pi+ | 80000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 80000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 80000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 80000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 948 | ||
| positive pion | pi+ | 80000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 928 | ||
| positive pion | pi+ | 80000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| positive pion | pi+ | 80000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 80000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| positive pion | pi+ | 80000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| positive pion | pi+ | 80000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| positive pion | pi+ | 80000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 80000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| positive pion | pi+ | 80000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1140 | ||
| positive pion | pi+ | 80000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| positive pion | pi+ | 80000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 | ||
| positive pion | pi+ | 80000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 80000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| positive pion | pi+ | 80000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 80000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 80000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 80000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| positive pion | pi+ | 80000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |||
| positive pion | pi+ | 80000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| positive pion | pi+ | 80000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 80000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 987 | ||
| positive pion | pi+ | 80000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 919 | ||
| positive pion | pi+ | 80000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 870 | ||
| positive pion | pi+ | 80000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 919 | ||
| positive pion | pi+ | 80000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 947 | ||
| positive pion | pi+ | 80000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 880 | ||
| positive pion | pi+ | 80000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 821 | ||
| positive pion | pi+ | 80000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 80000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| positive pion | pi+ | 80000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1230 | ||
| positive pion | pi+ | 80000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 904 | ||
| positive pion | pi+ | 80000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 923 | ||
| positive pion | pi+ | 80000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| positive pion | pi+ | 80000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 80000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 80000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 80000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 80000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 80000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 80000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1080 | ||
| positive pion | pi+ | 80000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1030 | ||
| positive pion | pi+ | 80000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 961 | ||
| positive pion | pi+ | 80000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 937 | ||
| positive pion | pi+ | 80000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1360 | ||
| positive pion | pi+ | 80000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| positive pion | pi+ | 80000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| positive pion | pi+ | 80000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1310 | ||
| positive pion | pi+ | 80000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 80000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| positive pion | pi+ | 80000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 80000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 80000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 80000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 80000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 80000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 80000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| positive pion | pi+ | 80000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 80000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 792 | ||
| positive pion | pi+ | 80000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 80000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1240 | ||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1170 | ||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 100000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 100000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| positive pion | pi+ | 100000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |||
| positive pion | pi+ | 100000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1010 | ||
| positive pion | pi+ | 100000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 985 | ||
| positive pion | pi+ | 100000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| positive pion | pi+ | 100000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| positive pion | pi+ | 100000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 100000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 100000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 100000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 100000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| positive pion | pi+ | 100000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 100000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| positive pion | pi+ | 100000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| positive pion | pi+ | 100000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 100000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| positive pion | pi+ | 100000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 100000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 100000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 100000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1460 | ||
| positive pion | pi+ | 100000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |||
| positive pion | pi+ | 100000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 100000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 100000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1050 | ||
| positive pion | pi+ | 100000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 975 | ||
| positive pion | pi+ | 100000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 917 | ||
| positive pion | pi+ | 100000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 960 | ||
| positive pion | pi+ | 100000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 100000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 935 | ||
| positive pion | pi+ | 100000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 868 | ||
| positive pion | pi+ | 100000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 100000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| positive pion | pi+ | 100000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 | ||
| positive pion | pi+ | 100000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1300 | ||
| positive pion | pi+ | 100000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 955 | ||
| positive pion | pi+ | 100000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 983 | ||
| positive pion | pi+ | 100000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1420 | ||
| positive pion | pi+ | 100000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| positive pion | pi+ | 100000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 100000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1300 | ||
| positive pion | pi+ | 100000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 100000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 | ||
| positive pion | pi+ | 100000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 100000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1300 | ||
| positive pion | pi+ | 100000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 100000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1160 | ||
| positive pion | pi+ | 100000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 100000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1020 | ||
| positive pion | pi+ | 100000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 980 | ||
| positive pion | pi+ | 100000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1440 | ||
| positive pion | pi+ | 100000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 100000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| positive pion | pi+ | 100000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 100000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1410 | ||
| positive pion | pi+ | 100000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1280 | ||
| positive pion | pi+ | 100000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 100000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1220 | ||
| positive pion | pi+ | 100000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 100000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1130 | ||
| positive pion | pi+ | 100000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 100000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 100000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 100000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 100000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 100000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 823 | ||
| positive pion | pi+ | 100000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 100000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1380 | ||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1420 | ||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1340 | ||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| positive pion | pi+ | 150000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 150000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| positive pion | pi+ | 150000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 150000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1170 | ||
| positive pion | pi+ | 150000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 150000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1550 | ||
| positive pion | pi+ | 150000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1450 | ||
| positive pion | pi+ | 150000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| positive pion | pi+ | 150000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 | ||
| positive pion | pi+ | 150000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| positive pion | pi+ | 150000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1400 | ||
| positive pion | pi+ | 150000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| positive pion | pi+ | 150000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1590 | ||
| positive pion | pi+ | 150000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1520 | ||
| positive pion | pi+ | 150000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1360 | ||
| positive pion | pi+ | 150000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| positive pion | pi+ | 150000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1340 | ||
| positive pion | pi+ | 150000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 150000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 150000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| positive pion | pi+ | 150000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| positive pion | pi+ | 150000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| positive pion | pi+ | 150000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 150000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1100 | ||
| positive pion | pi+ | 150000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1040 | ||
| positive pion | pi+ | 150000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 150000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 150000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 150000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 978 | ||
| positive pion | pi+ | 150000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 | ||
| positive pion | pi+ | 150000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| positive pion | pi+ | 150000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1590 | ||
| positive pion | pi+ | 150000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1530 | ||
| positive pion | pi+ | 150000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 | ||
| positive pion | pi+ | 150000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 150000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 150000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 150000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1630 | ||
| positive pion | pi+ | 150000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 150000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1440 | ||
| positive pion | pi+ | 150000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |||
| positive pion | pi+ | 150000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 | ||
| positive pion | pi+ | 150000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 150000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1610 | ||
| positive pion | pi+ | 150000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| positive pion | pi+ | 150000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1470 | ||
| positive pion | pi+ | 150000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1360 | ||
| positive pion | pi+ | 150000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| positive pion | pi+ | 150000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1250 | ||
| positive pion | pi+ | 150000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1190 | ||
| positive pion | pi+ | 150000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1110 | ||
| positive pion | pi+ | 150000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| positive pion | pi+ | 150000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| positive pion | pi+ | 150000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1690 | ||
| positive pion | pi+ | 150000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 150000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1530 | ||
| positive pion | pi+ | 150000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1610 | ||
| positive pion | pi+ | 150000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1490 | ||
| positive pion | pi+ | 150000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| positive pion | pi+ | 150000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1400 | ||
| positive pion | pi+ | 150000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 150000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1370 | ||
| positive pion | pi+ | 150000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 150000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 150000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| positive pion | pi+ | 150000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 150000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 899 | ||
| positive pion | pi+ | 150000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 150000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1540 | ||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1590 | ||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1480 | ||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1680 | ||
| positive pion | pi+ | 200000 | MeV | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 200000 | MeV | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1510 | ||
| positive pion | pi+ | 200000 | MeV | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |||
| positive pion | pi+ | 200000 | MeV | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1270 | ||
| positive pion | pi+ | 200000 | MeV | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 200000 | MeV | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 200000 | MeV | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1750 | ||
| positive pion | pi+ | 200000 | MeV | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1630 | ||
| positive pion | pi+ | 200000 | MeV | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1530 | ||
| positive pion | pi+ | 200000 | MeV | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 | ||
| positive pion | pi+ | 200000 | MeV | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1790 | ||
| positive pion | pi+ | 200000 | MeV | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200000 | MeV | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| positive pion | pi+ | 200000 | MeV | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1540 | ||
| positive pion | pi+ | 200000 | MeV | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1710 | ||
| positive pion | pi+ | 200000 | MeV | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1700 | ||
| positive pion | pi+ | 200000 | MeV | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| positive pion | pi+ | 200000 | MeV | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1620 | ||
| positive pion | pi+ | 200000 | MeV | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1450 | ||
| positive pion | pi+ | 200000 | MeV | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 200000 | MeV | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1290 | ||
| positive pion | pi+ | 200000 | MeV | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1810 | ||
| positive pion | pi+ | 200000 | MeV | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1660 | ||
| positive pion | pi+ | 200000 | MeV | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1390 | ||
| positive pion | pi+ | 200000 | MeV | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1310 | ||
| positive pion | pi+ | 200000 | MeV | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1200 | ||
| positive pion | pi+ | 200000 | MeV | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 | ||
| positive pion | pi+ | 200000 | MeV | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 200000 | MeV | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 | ||
| positive pion | pi+ | 200000 | MeV | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 200000 | MeV | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 | ||
| positive pion | pi+ | 200000 | MeV | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1660 | ||
| positive pion | pi+ | 200000 | MeV | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1550 | ||
| positive pion | pi+ | 200000 | MeV | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1890 | ||
| positive pion | pi+ | 200000 | MeV | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1850 | ||
| positive pion | pi+ | 200000 | MeV | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1180 | ||
| positive pion | pi+ | 200000 | MeV | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1210 | ||
| positive pion | pi+ | 200000 | MeV | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 200000 | MeV | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1890 | ||
| positive pion | pi+ | 200000 | MeV | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1670 | ||
| positive pion | pi+ | 200000 | MeV | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1670 | ||
| positive pion | pi+ | 200000 | MeV | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1430 | ||
| positive pion | pi+ | 200000 | MeV | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1840 | ||
| positive pion | pi+ | 200000 | MeV | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200000 | MeV | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1660 | ||
| positive pion | pi+ | 200000 | MeV | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200000 | MeV | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1650 | ||
| positive pion | pi+ | 200000 | MeV | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200000 | MeV | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| positive pion | pi+ | 200000 | MeV | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200000 | MeV | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1470 | ||
| positive pion | pi+ | 200000 | MeV | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1380 | ||
| positive pion | pi+ | 200000 | MeV | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 | ||
| positive pion | pi+ | 200000 | MeV | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 | ||
| positive pion | pi+ | 200000 | MeV | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1860 | ||
| positive pion | pi+ | 200000 | MeV | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1670 | ||
| positive pion | pi+ | 200000 | MeV | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1700 | ||
| positive pion | pi+ | 200000 | MeV | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 200000 | MeV | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1670 | ||
| positive pion | pi+ | 200000 | MeV | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1780 | ||
| positive pion | pi+ | 200000 | MeV | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1690 | ||
| positive pion | pi+ | 200000 | MeV | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1700 | ||
| positive pion | pi+ | 200000 | MeV | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.2 | |||
| positive pion | pi+ | 200000 | MeV | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.6 | |||
| positive pion | pi+ | 200000 | MeV | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1530 | ||
| positive pion | pi+ | 200000 | MeV | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.7 | |||
| positive pion | pi+ | 200000 | MeV | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1600 | ||
| positive pion | pi+ | 200000 | MeV | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 | ||
| positive pion | pi+ | 200000 | MeV | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |||
| positive pion | pi+ | 200000 | MeV | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 974 | ||
| positive pion | pi+ | 200000 | MeV | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |||
| positive pion | pi+ | 200000 | MeV | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 974 | ||
| positive pion | pi+ | 200000 | MeV | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1.3 | |||
| positive pion | pi+ | 200000 | MeV | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 |